合成路线1
该中间体在本合成路线中的序号:
(II) By condensation of 4-hydroxycarbazole (I) with epichlorohydrin (II) by means of NaOH in aqueous dioxane at 40 C to yield 4-(2,3-epoxypropoxy)carbazole (III), followed by treatment with isopropylamine (IV) in refluxing ethanol
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29480 |
4-Hydroxycarbazole; 9H-carbazol-4-ol
|
52602-39-8 |
C12H9NO |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
40171 |
9H-carbazol-4-yl 2-oxiranylmethyl ether; 4-(2-oxiranylmethoxy)-9H-carbazole
|
51997-51-4 |
C15H13NO2 |
详情 | 详情
|
(IV) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(III) The esterification of 3-(4-hydroxyphenyl)propionic acid (I) with methanol and H2SO4 gives the corresponding methyl ester (II), which by condensation with epichlorohydrin (III) by means of K2CO3 in refluxing acetone affords methyl 3-[4-(2,3-epoxypropoxy)phenyl]propionate (IV). Finally, the epoxide ring is opened by reaction with isopropylamine (V) in refluxing methanol, and a final treatment with ethereal HCl is performed.
【1】
Erhardt, P.W.; Woo, C.M.; Anderson, W.G.; Gorczynski, R.J.; Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function. J Med Chem 1982, 25, 12, 1408.
|
【2】
Erhardt, P.W.; Bogman, R.J.; O'Donnell, J.P. (Baxter International Inc.); Method for treatment or prophylaxis of cardiac disorders. EP 0053435; EP 0065542; US 4387103; WO 8201869 .
|
【3】
Serradell, M.N.; Castaner, J.; Badia, A.; Esmolol Hydrochloride. Drugs Fut 1984, 9, 3, 183.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25691 |
3-(4-hydroxyphenyl)propionic acid
|
501-97-3 |
C9H10O3 |
详情 | 详情
|
(II) |
30341 |
methyl 3-(4-hydroxyphenyl)propanoate; 4-Hydroxyphenylpropionic acid methyl ester; 3-(4-Hydroxyphenyl)propionic acid methyl ester
|
5597-50-2 |
C10H12O3 |
详情 | 详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
30342 |
methyl 3-[4-(2-oxiranylmethoxy)phenyl]propanoate
|
81147-94-6 |
C13H16O4 |
详情 | 详情
|
(V) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) For synthesizing alpha/beta-TGU a mixture of urazole (I), epichlorohydrin (II) and tetramethylammonium bromide or benzalcon A was heated to yield the corresponding chlorohydrin intermediate (III), which was converted to alpha/beta-TGU by addition of sodium hydroxide and purified by column chromatography or recrystallization.
【1】
Fischer, H.; et al. (Henkel KgA); N-Substituted polyglycidyl urazole compounds, processes for their production and pharmaceutical preparations. EP 0056962; JP 57142982; US 4801601 .
|
【2】
Castaner, J.; Serradell, M.N.; Triglycidylurazol. Drugs Fut 1984, 9, 3, 209.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30371 |
1,2,4-triazolidine-3,5-dione
|
3232-84-6 |
C2H3N3O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
30372 |
1,2,4-tris(2-oxiranylmethyl)-1,2,4-triazolidine-3,5-dione
|
|
C11H15N3O5 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(B) The condensation of ethyl p-hydroxyphenylacetate (I) with benzyl chloride (II) by means of sodium ethoxide in refluxing ethanol gives ethyl p-(benzyloxy)phenylacetate (III), which is reduced with LiAlH4 in THF to 2-(p-benzyloxyphenyl)ethanol (IV). The etherification of (IV) with cyclopropyl bromide (A) by means of NaH in hot DMF affords 4-(cyclopropylmethoxyethyl)-1-benzyloxybenzene (V), which is debenzylated by hydrogenation with H2 and Pd/C in methanol giving rise to p-(cyclopropylmethoxyethyl)phenol (VI). The condensation of (VI) with epichlorohydrin (B) by means of NaOH in water yields 1-[p-(cyclopropylmethoxyethyl)phenoxy]-2,3-epoxypropane (VII), which is treated with isopropylamine (C) and finally with HCl in ether.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(A) |
22277 |
Cyclopropyl bromide; 1-(Bromomethyl)cyclopropane
|
7051-34-5 |
C4H7Br |
详情 | 详情
|
(I) |
24994 |
Ethyl 2-(4-hydroxyphenyl)acetate
|
17138-28-2 |
C10H12O3 |
详情 | 详情
|
(II) |
19171 |
1-(Chloromethyl)benzene; Benzyl chloride
|
100-44-7 |
C7H7Cl |
详情 | 详情
|
(III) |
28637 |
Ethyl 2-[4-(benzyloxy)phenyl]acetate; p-(Benzyloxy)phenylacetate
|
|
C17H18O3 |
详情 |
详情
|
(IV) |
33328 |
2-(p-Benzyloxyphenyl)ethanol; 2-[4-(Benzyloxy)phenyl]-1-ethanol
|
|
C15H16O2 |
详情 |
详情
|
(V) |
33329 |
4-(Cyclopropylmethoxyethyl)-1-benzyloxybenzene; 1-(Benzyloxy)-4-[2-(cyclopropylmethoxy)ethyl]benzene; Benzyl 4-[2-(cyclopropylmethoxy)ethyl]phenyl ether
|
|
C19H22O2 |
详情 |
详情
|
(VI) |
33330 |
4-[2-(Cyclopropylmethoxy)ethyl]phenol; p-(Cyclopropylmethoxyethyl)phenol
|
|
C12H16O2 |
详情 |
详情
|
(VII) |
33331 |
2-([4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl)oxirane; 1-[p-(Cyclopropylmethoxyethyl)phenoxy]-2,3-epoxypropane; 4-[2-(Cyclopropylmethoxy)ethyl]phenyl 2-oxiranylmethyl ether
|
|
C15H20O3 |
详情 |
详情
|
(C) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(V) The reaction of 3,4-dihydro-2H-1-benzopyran-3,8-diol (I) with ethyl chloroformate by means of triethylamine in THF gives 3,4-dihydro-8-lethoxy carbonyloxyl-2H-1-benzopyran-3-ol (II), which is treated with nitric acid and acetic anhydride in acetonitrile to yield 3,4-dihydro-8-(ethoxycarbonyloxy)-2H-1-benzopyran-3-ol-3-nitrate (III). The hydrolysis of (III) with NaOH in methanol affords 3,4-dihydro-8-hydroxy-2H-1-benzopyran-3-ol 3-nitrate (IV), which is condensed with epichlorohydrin (V) by means of NaOH in water giving 3,4-dihydro-8-(2,3-epoxypropoxy)-2H-1-benzopyran-3-ol 3-nitrate (VI). Finally, this compound is treated with isopropylamine in refluxing ethanol.
【1】
Shiratsuohi, M.; Shimizu, N.; Shigyo, H.; Kyotani, Y.; Kunieda, H.; Kawamura, K.; Sato, S.; Akashi, T.; Nagakura, M. (Kowa Co., Ltd.); Dihydrobenzopyran compounds and pharmaceutical composition comprising said compounds. EP 0042299; JP 57007481; JP 82106619 . |
【2】
Blancafort, P.; Thorpe, P.J.; Serradell, M.N.; Castaner, J.; K-351. Drugs Fut 1983, 8, 6, 497.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30654 |
3,8-chromanediol
|
|
C9H10O3 |
详情 |
详情
|
(II) |
30655 |
ethyl 3-hydroxy-3,4-dihydro-2H-chromen-8-yl carbonate
|
|
C12H14O5 |
详情 |
详情
|
(III) |
30656 |
ethyl 3-(nitrooxy)-3,4-dihydro-2H-chromen-8-yl carbonate
|
|
C12H13NO7 |
详情 |
详情
|
(IV) |
30657 |
3-(nitrooxy)-8-chromanol
|
|
C9H9NO5 |
详情 |
详情
|
(V) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(VI) |
30658 |
3-(nitrooxy)-3,4-dihydro-2H-chromen-8-yl 2-oxiranylmethyl ether; 3-(nitrooxy)-8-(2-oxiranylmethoxy)chromane
|
|
C12H13NO6 |
详情 |
详情
|
(VII) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(VII) By reaction of 3-(2-methyl-2-aminopropyl)indole (I) and 2-(2,3-epoxypropoxy)benzonitrile (II) by heating at 120-40 C followed by a treatment with HCl in ethanol.
The starting products are obtained as follows:
1) The reaction of 3-(dimethylaminomethyl)indole (III) with 2-nitropropane (IV) by means of KOH gives 3-(2-methyl-2-nitropropyl)indole (V), which is then reduced with hydrazine and Raney-Ni in ethanol to yield (I).
2) The reaction of 2-hydroxybenzonitrile (VI) with epichlorohydrin (VII) by means of piperidine affords 2-(3-chloro-2-hydroxypropoxy)benzonitrile (VIII), which is epoxidized again to (II) by treatment with NaOH in hot THF-water.
【1】
Kreighbaum, W.E.; et al.; Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity. J Med Chem 1980, 23, 3, 285-289.
|
【2】
Weetman, D.F.; Castaner, J.; Bucindolol Hydrochloride. Drugs Fut 1981, 6, 7, 405.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10158 |
Piperidine
|
110-89-4 |
C5H11N |
详情 | 详情
|
(I) |
37566 |
2-(1H-indol-3-yl)-1,1-dimethylethylamine; 1-(1H-indol-3-yl)-2-methyl-2-propanamine
|
|
C12H16N2 |
详情 |
详情
|
(II) |
37567 |
2-(2-oxiranylmethoxy)benzonitrile
|
|
C10H9NO2 |
详情 |
详情
|
(III) |
37568 |
N,N-Dimethyl-1H-indole-3-methanamine;Gramine;N-(1H-indol-3-ylmethyl)-N,N-dimethylamine; 3-(dimethylaminomethyl)-indole[;]1H-indol-3-yl-N,N-dimethylmethanamine |
87-52-5 |
C11H14N2 |
详情 | 详情
|
(IV) |
21819 |
2-nitropropane
|
79-46-9 |
C3H7NO2 |
详情 | 详情
|
(V) |
37569 |
3-(2-methyl-2-nitropropyl)-1H-indole
|
|
C12H14N2O2 |
详情 |
详情
|
(VI) |
21990 |
2-hydroxybenzonitrile
|
611-20-1 |
C7H5NO |
详情 | 详情
|
(VII) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(VIII) |
37570 |
2-(3-chloro-2-hydroxypropoxy)benzonitrile
|
|
C10H10ClNO2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The condensation of 3-methylphenol (I) and epichlorohydrin (II) by means of NaOH gives 1,2-epoxy-3-(3-methylphenoxy)propane (III), which is then condensed with 3,4-dimethoxyphenylethylamine (V) by heating their mixture at 95-100 C.
【1】
Holmes, A.; Meyer, R.F.; New aminoalkanol compounds and methods for their production. FR 2163486; GB 1344976; JP 48067232 .
|
【2】
Milton, L.H.; et al.; Cardioselective beta-adrenergic blocking agents. 1. 1-[3,4-(dimethoxyphenethyl)amino]-3-aryloxy-2-propanols. J Med Chem 1975, 18, 2, 148-152.
|
【3】
Castaner, J.; Weetman, D.F.; Bevantol. Drugs Fut 1977, 2, 8, 500.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17793 |
m-cresol; m-Methylphenol
|
108-39-4 |
C7H8O |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
33968 |
2-[(3-methylphenoxy)methyl]oxirane; 3-methylphenyl 2-oxiranylmethyl ether
|
|
C10H12O2 |
详情 |
详情
|
(V) |
10098 |
2-(3,4-Dimethoxyphenyl)-1-ethanamine; 3,4-Dimethoxyphenethylamine; 2-(3,4-Dimethoxyphenyl)ethylamine
|
120-20-7 |
C10H15NO2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The condensation of 3-methylphenol (I) with epichlorohydrin (II) by means of a catalytic amount of piperidine gives 1-(3-methylphenoxy)-3-chloro-2-propanol (IV), which is then condensed with 3,4-dimethoxyphenylethylamine (V) by heating their mixture at 95-100 C.
【1】
Holmes, A.; Meyer, R.F.; New aminoalkanol compounds and methods for their production. FR 2163486; GB 1344976; JP 48067232 .
|
【2】
Milton, L.H.; et al.; Cardioselective beta-adrenergic blocking agents. 1. 1-[3,4-(dimethoxyphenethyl)amino]-3-aryloxy-2-propanols. J Med Chem 1975, 18, 2, 148-152.
|
【3】
Castaner, J.; Weetman, D.F.; Bevantol. Drugs Fut 1977, 2, 8, 500.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17793 |
m-cresol; m-Methylphenol
|
108-39-4 |
C7H8O |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
33967 |
1-chloro-3-(3-methylphenoxy)-2-propanol
|
|
C10H13ClO2 |
详情 |
详情
|
(V) |
10098 |
2-(3,4-Dimethoxyphenyl)-1-ethanamine; 3,4-Dimethoxyphenethylamine; 2-(3,4-Dimethoxyphenyl)ethylamine
|
120-20-7 |
C10H15NO2 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) [2H]-Labeled RSU-1069 is synthesized as follows:
The condensation of 2-nitroimidazole (I) with 3-chloro-1,2-epoxypropane (II) gives 1-(3-chloro-2-hydroxypropyl)-2-nitroimidazole (III), which is oxidized with CrO3 - H2SO4 in acetone yielding 1-(3-chloro-2-oxopropyl)-2-nitroimidazole (IV). The reduction of (IV) with NaB[2H]4 in ethanol affords 1-(3-chloro-2-hydroxy-2(2H)-propyl)-2-nitroimidazole (V), which is cyclized with NaOH to the corresponding labeled epoxide (VI). Finally, this compound is condensed with aziridine (VII) by means of triethylamine in refluxing ethanol.
【1】
Webb, P.; Threadgill, M.D.; Labelled compounds of interest as antitumour agents. Part II (1). Synthesis of 2H and 3H isotopomers of RSU 1069 and Ro 03-8799 (pimonidazole). J Label Compd Radiopharm 1990, 28, 3, 257.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III),(V) |
10147 |
1-Chloro-3-(2-nitro-1H-imidazol-1-yl)-2-propanol
|
|
C6H8ClN3O3 |
详情 |
详情
|
(I) |
10145 |
2-Nitro-1H-imidazole; 2-Nitroimidazole
|
527-73-1 |
C3H3N3O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
10148 |
1-Chloro-3-(2-nitro-1H-imidazol-1-yl)acetone
|
|
C6H6ClN3O3 |
详情 |
详情
|
(V) |
44588 |
1-chloro-3-(2-nitro-1H-imidazol-1-yl)-2-propanol
|
|
C6H8ClN3O3 |
详情 |
详情
|
(VI) |
10150 |
2-Nitro-1-(2-oxiranylmethyl)-1H-imidazole
|
|
C6H7N3O3 |
详情 |
详情
|
(VI) |
44589 |
2-nitro-1-(2-oxiranylmethyl)-1H-imidazole
|
|
C6H7N3O3 |
详情 |
详情
|
(VII) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(II) [2H]-Labeled pimonidazole is synthesized as follows:
The condensation of 2-nitroimidazole (I) with 3-chloro-1,2-epoxypropane (II) gives 1-(3-chloro-2-hydroxypropyl)-2-nitroimidazole (III), which is oxidized with CrO3 - H2SO4 in acetone yielding 1-(3-chloro-2-oxopropyl)-2-nitroimidazole (IV). The reduction of (IV) with NaB[2H]4 in ethanol affords 1-(3-chloro-2-hydroxy-2(2H)-propyl)-2-nitroimidazole (V), which is cyclized with NaOH to the corresponding labeled epoxide (VI). Finally, this compound is condensed with piperidine (VII) in refluxing ethanol.
【1】
Webb, P.; Threadgill, M.D.; Labelled compounds of interest as antitumour agents. Part II (1). Synthesis of 2H and 3H isotopomers of RSU 1069 and Ro 03-8799 (pimonidazole). J Label Compd Radiopharm 1990, 28, 3, 257.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III),(V) |
10147 |
1-Chloro-3-(2-nitro-1H-imidazol-1-yl)-2-propanol
|
|
C6H8ClN3O3 |
详情 |
详情
|
(I) |
10145 |
2-Nitro-1H-imidazole; 2-Nitroimidazole
|
527-73-1 |
C3H3N3O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
10148 |
1-Chloro-3-(2-nitro-1H-imidazol-1-yl)acetone
|
|
C6H6ClN3O3 |
详情 |
详情
|
(V) |
44588 |
1-chloro-3-(2-nitro-1H-imidazol-1-yl)-2-propanol
|
|
C6H8ClN3O3 |
详情 |
详情
|
(VI) |
10150 |
2-Nitro-1-(2-oxiranylmethyl)-1H-imidazole
|
|
C6H7N3O3 |
详情 |
详情
|
(VI) |
44589 |
2-nitro-1-(2-oxiranylmethyl)-1H-imidazole
|
|
C6H7N3O3 |
详情 |
详情
|
(VII) |
10158 |
Piperidine
|
110-89-4 |
C5H11N |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) The condensation of epichlorohydrin (I) with 7-hydroxyflavone (II) by means of NaOH in ethanol - water gives 7-(2,3-epoxypropoxy)fIavone (III), which is then treated with propylamine (IV) in methanol, and neutralized with maleic acid.
【1】
Wu, E.S.-C. (Pennwalt Corp.); Antihypertensive agents. EP 0064165; US 4501755 .
|
【2】
Castaner, J.; Prous, J.; Flavodilol maleate. Drugs Fut 1986, 11, 10, 837.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
37495 |
Maleic acid; (Z)-2-Butenedioic acid
|
110-16-7 |
C4H4O4 |
详情 | 详情
|
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
23921 |
7-hydroxy-2-phenyl-4H-chromen-4-one
|
6665-86-7 |
C15H10O3 |
详情 | 详情
|
(III) |
23922 |
7-(2-oxiranylmethoxy)-2-phenyl-4H-chromen-4-one
|
|
C18H14O4 |
详情 |
详情
|
(IV) |
23923 |
1-propanamine
|
107-10-8 |
C3H9N |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) 1) The reaction of phenol (I) with epichlorohydrin (II) gives 1,2-epoxy-3-phenoxypropane (III), which is treated with isopropylamine (IV) to afford 3-(isopropylamino)-1-phenoxy-2-propanol (V). Cyclization of (V) with diethyl carbonate (VI) yields 3-isopropyl-5-(phenoxymethyloxazolidin-2-one) (VII), which is chloromethylated with formaldehyde - HCl giving 3-isopropyl-5-(4-chloromethylphenoxymethyl)oxazolidin-2-one (VIII). Etherification of (VIII) with ethylene glycol monoisopropyl ether (IX) yields the corresponding ether (XI), which is finally deprotected by alkaline hydrolysis.
【1】
Harting, J.; et al.; Pharmacodynamic profile of the selective beta1-adrenoceptor antagonist bisoprolol. Arzneim-Forsch Drug Res 1986, 36, 2, 200.
|
【2】
Castaner, J.; Prous, J.; Bisoprolol fumarate. Drugs Fut 1986, 11, 10, 829.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
23932 |
2-(phenoxymethyl)oxirane; oxiranylmethyl phenyl ether
|
122-60-1 |
C9H10O2 |
详情 | 详情
|
(IV) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
(V) |
23934 |
1-(isopropylamino)-3-phenoxy-2-propanol
|
|
C12H19NO2 |
详情 |
详情
|
(VI) |
17470 |
diethyl carbonate; diethylcarbonate
|
105-58-8 |
C5H10O3 |
详情 | 详情
|
(VII) |
23936 |
3-isopropyl-5-(phenoxymethyl)-1,3-oxazolidin-2-one
|
|
C13H17NO3 |
详情 |
详情
|
(VIII) |
23937 |
5-[[4-(chloromethyl)phenoxy]methyl]-3-isopropyl-1,3-oxazolidin-2-one
|
|
C14H18ClNO3 |
详情 |
详情
|
(IX) |
23938 |
2-isopropoxy-1-ethanol
|
109-59-1 |
C5H12O2 |
详情 | 详情
|
(X) |
23939 |
5-([4-[(2-isopropoxyethoxy)methyl]phenoxy]methyl)-3-isopropyl-1,3-oxazolidin-2-one
|
|
C19H29NO5 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(IV) The condensation of 4-hydroxybenzyl alcohol (I) with 2-isopropoxyethanol (II) by heating at 150 C gives the corresponding benzyl ether (III), which is condensed with epichlorohydrin (IV) to yield the adduct (V). Finally, this compound is treated with isopropylamine in ethanol.
【1】
Schliep, H.-J.; Enenkel, H.-J.; Minck, K.; Becker, K.-H.; Jonas, R. (Merck Patent GmbH); Phenoxy-amino-propanols. US 4258062 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29474 |
4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol
4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol
|
623-05-2 |
C7H8O2 |
详情 | 详情
|
(II) |
23938 |
2-isopropoxy-1-ethanol
|
109-59-1 |
C5H12O2 |
详情 | 详情
|
(III) |
40522 |
4-[(2-isopropoxyethoxy)methyl]phenol
|
|
C12H18O3 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
40523 |
4-[(2-isopropoxyethoxy)methyl]phenyl 2-oxiranylmethyl ether; 2-([4-[(2-isopropoxyethoxy)methyl]phenoxy]methyl)oxirane
|
|
C15H22O4 |
详情 |
详情
|
(VI) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) The condensation of sodium 2-(2-exo-norbornyl)phenoxide [from 2-bicyclo[2.2.1]hept-2-ylphenol (I) and sodium] with epichlorohydrin (II) gives (III), which is then treated with isopropylamine (IV) and finally with isopropanolic HCl.
【1】
FR 75/09997; FR 76/24360 .
|
【2】
Michaud, R.; Bornaprolol hydrochloride. Drugs Fut 1982, 7, 2, 91.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37059 |
2-bicyclo[2.2.1]hept-2-ylphenol
|
|
C13H16O |
详情 |
详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
37060 |
2-[(2-bicyclo[2.2.1]hept-2-ylphenoxy)methyl]oxirane; 2-bicyclo[2.2.1]hept-2-ylphenyl 2-oxiranylmethyl ether
|
|
C16H20O2 |
详情 |
详情
|
(IV) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(A) The chlorohydrin (II) is obtained by the reaction of p-chlorobenzylmagnesium chloride (I) with epichlorohydrin (A) in ether. This is then converted to the crystalline alcohol (III) by reaction with sodium imidazole (B) in DMF. On treatment with thionyl chloride is converted to the corresponding chloro compound (IV). When (IV) is reacted with 2,6-dichloro thiophenol (C) in the presence of anhydrous potassium carbonate in acetone, the free base of butoconazole is formed. Neutralization of the free base (V) with nitric acid gives butoconazole.
【1】
Walker, K.A.M.; et al.; 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenylthio)n-butil]-1H-imidazole nitrate, a new patent antifungal agent. J Med Chem 1978, 21, 8, 840.
|
【2】
Arya, V.P.; Butoconazole nitrate. Drugs Fut 1979, 4, 2, 89.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(I) |
33290 |
Bromo(4-chlorobenzyl)magnesium; p-Chlorobenzylmagnesium chloride
|
|
C7H6BrClMg |
详情 |
详情
|
(II) |
33291 |
1-chloro-4-(4-chlorophenyl)-2-butanol
|
|
C10H12Cl2O |
详情 |
详情
|
(III) |
16486 |
4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanol
|
|
C13H15ClN2O |
详情 |
详情
|
(IV) |
33292 |
1-[2-chloro-4-(4-chlorophenyl)butyl]-1H-imidazole
|
|
C13H14Cl2N2 |
详情 |
详情
|
(V) |
33294 |
1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl]-1H-imidazole; 3-(4-chlorophenyl)-1-(1H-imidazol-1-ylmethyl)propyl 2,6-dichlorophenyl sulfide
|
|
C19H17Cl3N2S |
详情 |
详情
|
(C) |
33293 |
2,6-Dichloro thiophenol; 2,6-Dichlorobenzenethiol; 2,6-Dichlorophenylhydrosulfide
|
24966-39-0 |
C6H4Cl2S |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(I) It can be prepared in two different ways:
1) The reaction of 1-chloro-2,3-propylene oxide (I) with tert-butylamine (II) in ether yields 1-chloro-3-tert-butylamino-2-propanol (III), which is condensed with 2,3-xylenol (IV) by means of KOH in ether-water.
2) By heating a mixture of 1-tert-butyl-3-azetidinol (V) and 2,3-xylenol (IV) at 155 C with KOH.
【1】
Suzuki, Y.; et al.; JP 45029294 .
|
【2】
Tsukamoto, K.; et al.; JP 46028534 .
|
【3】
Castaner, J.; Weetman, D.F.; D-32. Drugs Fut 1977, 2, 2, 91.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(III) |
31720 |
1-(tert-butylamino)-3-chloro-2-propanol
|
|
C7H16ClNO |
详情 |
详情
|
(IV) |
40074 |
2,3-dimethylphenol
|
526-75-0 |
C8H10O |
详情 | 详情
|
(V) |
40075 |
1-(tert-butyl)-3-azetidinol
|
13156-04-2 |
C7H15NO |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(IV) This compound has been obtained in two related ways:
1. The reaction of 2-(2-bromoethoxy)anisole (I) with benzylamine (II) by heating at 80 C gives the secondary amine (III), which is condensed with epichlorohydrin (IV) by heating at 60 C to yield the isopropanol derivative (V). The condensation of (V) with 4-hydroxycarbazole (VI) by means of K2CO3 in refluxing dioxane affords the adduct (VII), which is finally debenzylated by hydrogenolysis with H2 over Pd/C in ethanol/water.
2. The condensation of the secondary amine (III) with 4-(2,3-epoxypropoxy)carbazole (VIII) in refluxing ethanol gives the already reported adduct (VII), which is debenzylated as indicated.
【1】
Seres, P.; Cselenyak, J.; Nagy, K.; Simig, G.; Gregor, T.; Nagy, P.K.; Greff, Z.; Balazs, L.; Barkoczy, J.; Vereczkey, G.D.; Nemeth, N.; Szabo, T.; Ratkai, Z.; Doman, I. (Egis Pharmaceuticals Ltd.); Process and intermediates for preparing 1-[9'H-carbazol-4'-yloxy]-3-[2''-(2'''-methoxy-phenoxy)ethyl]amino]-propan-2-ol (carvedilol). EP 0918055 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51402 |
2-(2-Bromoethoxy)methoxybenzene; 1-Bromo-2-(2-methoxyphenoxy)ethane
|
4463-59-6 |
C9H11BrO2 |
详情 | 详情
|
(II) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
(III) |
30528 |
N-benzyl-2-(2-methoxyphenoxy)-1-ethanamine; N-benzyl-N-[2-(2-methoxyphenoxy)ethyl]amine
|
|
C16H19NO2 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
51403 |
1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-chloro-2-propanol
|
|
C19H24ClNO3 |
详情 |
详情
|
(VI) |
29480 |
4-Hydroxycarbazole; 9H-carbazol-4-ol
|
52602-39-8 |
C12H9NO |
详情 | 详情
|
(VII) |
51404 |
1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy)-2-propanol
|
|
C31H32N2O4 |
详情 |
详情
|
(VIII) |
40171 |
9H-carbazol-4-yl 2-oxiranylmethyl ether; 4-(2-oxiranylmethoxy)-9H-carbazole
|
51997-51-4 |
C15H13NO2 |
详情 | 详情
|
合成路线18
该中间体在本合成路线中的序号:
(IV) The acylation of 8-hydroxy-1,2,3,4-tetrahydroquinoline (I) with nicotinoyl chloride (II) by means of triethylamine in benzene gives 8-hydroxy-1-nicotinoyl-1,2,3,4-tetrahydroquinoline (III), which is condensed with epichlorohydrin (IV) by means of potassium tert-butoxide in DMF to yield 1-nicotinoyl-8-(2,3-epoxy-1-propoxy)-1,2,3,4-tetrahydroquinoline (V). Finally, this compound is condensed with isopropylamine (VI) in ethanol.
【1】
Graewinger, O.; Raabe, T.; Beyerle, R.; Scholtholt, J.; Nitz, R.E.; 1-Acyl-8-(3-amino-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinolines, compositions and use. DD 153368; DE 2934609; EP 0025864; JP 56034668; US 4335123 .
|
【2】
Castaner, J.; Serradell, M.N.; Hillier, K.; Nicainoprol. Drugs Fut 1984, 9, 10, 749.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16022 |
1,2,3,4-tetrahydro-8-quinolinol
|
|
C9H11NO |
详情 |
详情
|
(II) |
10753 |
Nicotinoyl chloride
|
|
C6H4ClNO |
详情 |
详情
|
(III) |
34334 |
[8-hydroxy-3,4-dihydro-1(2H)-quinolinyl](3-pyridinyl)methanone
|
|
C15H14N2O2 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
34335 |
[8-(2-oxiranylmethoxy)-3,4-dihydro-1(2H)-quinolinyl](3-pyridinyl)methanone
|
|
C18H18N2O3 |
详情 |
详情
|
(VI) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(B) This compound can be prepared in several ways from the lactone (I), which is obtained by treatment of benzyl cyanide (A) and epichlorhydrin (B) with sodium amide:
1) The opening of lactone (I) with SOBr2-ethanol gives a bromo ester, which is treated successively by ammonia and sodium hydroxide to yield the amino acid (II). The reaction of (II) with SOCl2 and diethylamine in ethanol gives the final product, which is converted to the hydrochloric salt by treatment with HCl ethanol.
2) Lactone (I), opened with 33% HBr-AcOH, gives the bromo acid (III), which is treated by SOCl2 and then diethylamine in ethanol. The bromoamide (IV) reacts with potassium phthalimide and is deprotected by hydrazine or methylamine to yield, after salification, title compound.
3) Lactone (I) is treated by potassium phthalimide and then SOCl2 and diethylamine in EtOH to give compound (V), treated as above.
4) Bromoamide (IV) can be treated by hexamethylenetetramine in butanol and hydrolyzed by refluxing with 15% HCl in ethanol.
【1】
Kasama, S.; et al.; Synthesis 1978, 4, 10, 304.
|
【2】
Patoiseau, J.-F.; Mouzin, G.; Bonnaud, B.; Cousse, H. (Pierre Fabre Medicament); Process for the preparation of (Z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl-cyclopropane. EP 0200638; FR 2581059 .
|
【3】
Cousse, H.; Hascoet, P. (Pierre Fabre Medicament); Industrial process for the production of midalcipran. FR 2581060 .
|
【4】
Mouzin, G.; Cousse, H.; Bonnaud, B.; Morre, M.; Stenger, A. (Pierre Fabre Médicament); 1-Aryl-2-aminomethyl cyclopropane carboxyamide (Z) deivatives and their use as useful drugs in the treatment of disturbances of the central nervous system. EP 0068999; FR 2508035; JP 58004752; US 4478836 . |
【5】
Briley, M.; Midalcipran Hydrochloride. Drugs Fut 1986, 11, 1, 21.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(A) |
17046 |
Phenylacetonitrile; 2-phenylacetonitrile; Benzyl cyanide
|
140-29-4 |
C8H7N |
详情 | 详情
|
(F) |
27890 |
Potassium phthalimide
|
1074-82-4 |
C8H4KNO2 |
详情 | 详情
|
(G) |
28148 |
1-([2-[(diethylamino)carbonyl]-2-phenylcyclopropyl]methyl)-3,5,7-triaza-1-azoniatricyclo[3.3.1.1(3,7)]decane
|
|
C21H32N5O |
详情 |
详情
|
(E) |
28150 |
2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-1-phenylcyclopropanecarboxylic acid
|
|
C19H15NO4 |
详情 |
详情
|
(D) |
28151 |
2-(hydroxymethyl)-1-phenylcyclopropanecarboxylic acid
|
|
C11H12O3 |
详情 |
详情
|
(I) |
28144 |
1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one
|
|
C11H10O2 |
详情 |
详情
|
(II) |
28145 |
2-(aminomethyl)-1-phenylcyclopropanecarboxylic acid
|
|
C11H13NO2 |
详情 |
详情
|
(III) |
28146 |
2-(bromomethyl)-1-phenylcyclopropanecarboxylic acid
|
|
C11H11BrO2 |
详情 |
详情
|
(IV) |
28147 |
2-(bromomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide
|
|
C15H20BrNO |
详情 |
详情
|
(V) |
28149 |
2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropanecarboxamide
|
|
C23H24N2O3 |
详情 |
详情
|
(C) |
28143 |
2-(hydroxymethyl)-1-phenylcyclopropanecarboxylic acid
|
|
C11H12O3 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(II) The condensation of N-methyl-4-hydroxyisocarbostyril (I) with epichlorohydrin (II) by means of sodium methoxide in hot methanol gives 4-(2,3-epoxypropoxy)-N-methylisocarbostyril (III), which is then treated with tert-butylamine (IV) in methanol, and with HCl.
【1】
Fukushima, H.; Suzuki, Y. (Nisshin Flour Milling Co., Ltd.); Isocarbostyril derivatives. DE 2631080; GB 1501149; JP 52012178 .
|
【2】
Serradell, M.N.; Blancafort, P.; Thorpe, P.J.; Castaner, J.; N-696. Drugs Fut 1982, 7, 12, 889.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
32094 |
4-hydroxy-2-methyl-1(2H)-isoquinolinone
|
|
C10H9NO2 |
详情 |
详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
32095 |
2-methyl-4-(2-oxiranylmethoxy)-1(2H)-isoquinolinone
|
|
C13H13NO3 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(II) By reaction of 1-(3-chloro-2-hydroxypropyl)-4-(2-methoxyphenyl)piperazine (III), obtained from 2-methoxyphenylpiperazine (I) and epichlorohydrine (II), with the sodium salt of 3,4,5-trimethoxyphenol (IV) in refluxing dioxane.
【1】
Kleemann, A.; DE 2814168 .
|
【2】
Engel, J.; Jakovlev, V.; Kleemann, A.; Enciprazine. Drugs Fut 1981, 6, 5, 278.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11882 |
1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine
|
35386-24-4 |
C11H16N2O |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
37161 |
1-chloro-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-propanol
|
|
C14H21ClN2O2 |
详情 |
详情
|
(IV) |
37162 |
sodium 3,4,5-trimethoxybenzenolate
|
|
C9H11NaO4 |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(II) By reaction of 3,4,5-trimethoxyphenoxyglycidylether (VI) [obtained by reaction of 3,4,5-trimethoxyphenol (V) with epichlorohydrine (II)] with 1-(2-methoxyphenyl)piperazine (I) in refluxing isopropanol.
【1】
Kleemann, A.; DE 2814168 .
|
【2】
Engel, J.; Jakovlev, V.; Kleemann, A.; Enciprazine. Drugs Fut 1981, 6, 5, 278.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11882 |
1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine
|
35386-24-4 |
C11H16N2O |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
37163 |
3,4,5-trimethoxyphenol
|
|
C9H12O4 |
详情 |
详情
|
(VI) |
37164 |
2,3-dimethoxy-5-(2-oxiranylmethoxy)phenyl methyl ether; 2-[(3,4,5-trimethoxyphenoxy)methyl]oxirane
|
|
C12H16O5 |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
(A) Compound can be prepared in several different ways:
1) The reaction of 2-acetyl-7-hydroxybenzofuran (I) with epichlorohydrin by means of piperidine hydrochloride (A) at 105 C gives 2-acetyl-7-(2,3-epoxypropoxy)benzofuran (II), which is then condensed with isopropylamine (B) in refluxing ethanol.
2) By reaction of (I) with 1-chloro-3-isopropylamino-2-propanol (C) by means of NaOH at 80 C in a sealed tube.
3) By reductocondensation of 2-[1,1-(ethylenedioxy)ethyl]-7-[2-oxo-3-(hydroxyimino)propoxy]benzofuran (III) with acetone by means of H2 and PtO2 in ethanol, followed by hydrolysis of the reduced product with HCl in ethanol.
4) The reaction of 2-[1,1-(ethylenedioxy)ethyl]-7-glyoxylmethoxybenz-furan (IV) with isopropylamine (B) in ethanol gives the corresponding Schiff base (V), which is then reduced with NaBH4 and hydrolyzed with HCl in ethanol.
5) By hydrolysis of 3-isopropyl-5-(2-acetyl-7-benzofuryloxymethyl)oxazolidinone (VI) with aqueous refluxing NaOH.
6) By reaction of 2-acetyl-7-(2-hydroxy-3-aminopropoxy)benzofuran (VII) with isopropyl bromide (D) in ethanol at 100 C.
【1】
Ito, K.; Ikemoto, M.; Kimura, K.; Uchida, K.; Nakanishi, T.; JP 7436664 .
|
【2】
Ito, K.; Ikemoto, M.; Kimura, K.; Uchida, K.; Nakanishi, T.; JP 7442664 .
|
【3】
Ito, K.; Ikemoto, M.; Kimura, K.; Uchida, K.; Nakanishi, T.; JP 7441358 .
|
【4】
Ito, K.; Ikemoto, M.; Kimura, K.; Nakanishi, T.; JP 7443960 .
|
【5】
Ito, K.; Ikemoto, M.; Kimura, K.; Uchida, K.; Nakanishi, T.; JP 7443961 .
|
【6】
Ito, K.; Ikemoto, M.; Kimura, K.; Nakanishi, T. (Kaken Pharmaceutical Co., Ltd.); 2-Substittuted-(2-hydroxy-3-lower alkalinopropoxy)benzofurans. DE 2223184; FR 2137901; JP 7242747; US 3853923 .
|
【7】
Castaner, J.; Blancafort, P.; Weetman, D.F.; Serradell, M.N.; Befunolol. Drugs Fut 1981, 6, 10, 601.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
(D) |
32658 |
2-bromopropane
|
75-26-3 |
C3H7Br |
详情 | 详情
|
(I) |
32291 |
1-(7-hydroxy-1-benzofuran-2-yl)-1-ethanone
|
40020-87-9 |
C10H8O3 |
详情 | 详情
|
(II) |
32292 |
1-[7-(2-oxiranylmethoxy)-1-benzofuran-2-yl]-1-ethanone
|
|
C13H12O4 |
详情 |
详情
|
(III) |
32293 |
3-[[2-(2-methyl-1,3-dioxolan-2-yl)-1-benzofuran-7-yl]oxy]-2-oxopropanal oxime
|
|
C15H15NO6 |
详情 |
详情
|
(IV) |
32294 |
3-[[2-(2-methyl-1,3-dioxolan-2-yl)-1-benzofuran-7-yl]oxy]-2-oxopropanal
|
|
C15H14O6 |
详情 |
详情
|
(V) |
32295 |
1-(isopropylimino)-3-[[2-(2-methyl-1,3-dioxolan-2-yl)-1-benzofuran-7-yl]oxy]acetone
|
|
C18H21NO5 |
详情 |
详情
|
(VI) |
32296 |
5-[[(2-acetyl-1-benzofuran-7-yl)oxy]methyl]-3-isopropyl-1,3-oxazolidin-2-one
|
|
C17H19NO5 |
详情 |
详情
|
(VII) |
32297 |
1-[7-(3-amino-2-hydroxypropoxy)-1-benzofuran-2-yl]-1-ethanone
|
|
C13H15NO4 |
详情 |
详情
|
(C) |
32298 |
1-chloro-3-(isopropylamino)-2-propanol
|
|
C6H14ClNO |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(II) 1) By condensation of phenol (I) with 1-n-butoxy-2,3-epoxypropane (VII) in presence of potassium hydroxide.
2) By condensation of phenol (I) with 1-chloro-2,3-epoxypropane (II) followed either by addition of n-butanol (VI) in presence of a Lewis acid or in presence of a base (IV).
【1】
Hoffmann, H.; et al.; Procedimiento de fabricacion de sustancias medicinalmente activas y metodo de preparacion de medicamentos de accion coleretica. ES 402799; FR 2134389; GB 1393451; US 3839587 .
|
【2】
Janiak, P. St.; Febuprol. Drugs Fut 1978, 3, 3, 191.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
33456 |
1-chloro-3-phenoxy-2-propanol
|
|
C9H11ClO2 |
详情 |
详情
|
(IV) |
33457 |
sodium 1-butanolate; Sodium butoxide; Sodium n-butoxide
|
2372-45-4 |
C4H9NaO |
详情 | 详情
|
(V) |
23932 |
2-(phenoxymethyl)oxirane; oxiranylmethyl phenyl ether
|
122-60-1 |
C9H10O2 |
详情 | 详情
|
(VI) |
29766 |
butanol; n-butanol; 1-butanol
|
71-36-3 |
C4H10O |
详情 | 详情
|
(VII) |
33458 |
2-(butoxymethyl)oxirane; butyl 2-oxiranylmethyl ether
|
2426-08-6 |
C7H14O2 |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
(A) 4-Benzyloxy-indole-2-carboxylic acid (I) is converted into the corresponding dimethylamide (III), via the corresponding acid chloride (II); the dimethylamide (III) is reduced with LiAlH4 to give 4-benzyloxy-2-dimethylaminomethyl-indole (IV), which is hydrogenated to 4-hydroxy-2-methyl-indole (V). The reaction of (V) with epichlorohydrin (A) in aqueous NaOH gives the crude epoxide which without isolation is treated with isopropylamine (B) in refluxing dioxane.
【1】
Seemann, F.; et al.; Synthetic indoles. 10. Chemistry of 4-hydroxy-indoles. Helv Chim Acta 1971, 54, 8, 2411-19.
|
【2】
Troxler, F.; Hofmann, A.; Verfahren zur Herstellung neuer Indolderivate. AT 316542B; CH 502337 .
|
【3】
Troxler, F.; Hofmann, A.; Verfahren zur Herstellung neuer Indolderivate. CH 543505 .
|
【4】
Weetman, D.F.; Castaner, J.; Mepindolol. Drugs Fut 1978, 3, 5, 381.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
(I) |
33536 |
4-(benzyloxy)-1H-indole-2-carboxylic acid
|
|
C16H13NO3 |
详情 |
详情
|
(II) |
33537 |
4-(benzyloxy)-1H-indole-2-carbonyl chloride
|
|
C16H12ClNO2 |
详情 |
详情
|
(III) |
33538 |
4-(benzyloxy)-N,N-dimethyl-1H-indole-2-carboxamide
|
|
C18H18N2O2 |
详情 |
详情
|
(IV) |
33539 |
N-[[4-(benzyloxy)-1H-indol-2-yl]methyl]-N,N-dimethylamine; [4-(benzyloxy)-1H-indol-2-yl]-N,N-dimethylmethanamine
|
|
C18H20N2O |
详情 |
详情
|
(V) |
33540 |
4-Hydroxy-2-methylindole; 2-Methyl-1H-indol-4-ol
|
35320-67-3 |
C9H9NO |
详情 | 详情
|
合成路线26
该中间体在本合成路线中的序号:
(A) The reaction of 4-hydroxy-2-methyl-indole (V) with 1-(N-benzylisopropylamino)-3-chloro-2-propanol (D) by means of NaOH in refluxing aqueous dioxane yields the corresponding benzylamine (X), which is debenzylated by catalytic hydrogenation.
The reaction of 4-hydroxy-2-methyl-indole (V) with epichlorohydrin (A) and benzylamine (B) gives 4-(3-benzylamino-2-hydroxypropoxy)-2-methyl-indole (XI), which is debenzylated by hydrogenolysis to 4-(3-amino-2-hydroxypropoxy)-2-methyl-indole (XII). The condensation of (XII) with refluxing acetone (C) affords the corresponding N-isopropylidene derivative (XIII), which is finally hydrogenated with H2 over Pd/C in methanol.
【1】
Seemann, F.; et al.; Synthetic indoles. 10. Chemistry of 4-hydroxy-indoles. Helv Chim Acta 1971, 54, 8, 2411-19.
|
【2】
Troxler, F.; Verfahren zur Herstellung neuer Indolderivate. CH 472404; ES 337457 .
|
【3】
Troxler, F.; Verfahren zur Herstellung neuer Indolderivate. CH 469002; ES 337458 .
|
【4】
Troxler, F.; Verfahren zur Herstellung von neuem 4-(2-Hydroxy-3-isopropylaminopropoxy)-2-methylindol und seiner Saureadditionssalze Indolderivate. AT 317199 .
|
【5】
Weetman, D.F.; Castaner, J.; Mepindolol. Drugs Fut 1978, 3, 5, 381.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
(D) |
33549 |
1-[benzyl(isopropyl)amino]-3-chloro-2-propanol
|
|
C13H20ClNO |
详情 |
详情
|
(V) |
33540 |
4-Hydroxy-2-methylindole; 2-Methyl-1H-indol-4-ol
|
35320-67-3 |
C9H9NO |
详情 | 详情
|
(X) |
33548 |
1-[benzyl(isopropyl)amino]-3-[(2-methyl-1H-indol-4-yl)oxy]-2-propanol
|
|
C22H28N2O2 |
详情 |
详情
|
(XI) |
33545 |
1-(benzylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]-2-propanol
|
|
C19H22N2O2 |
详情 |
详情
|
(XII) |
33546 |
1-amino-3-[(2-methyl-1H-indol-4-yl)oxy]-2-propanol
|
|
C12H16N2O2 |
详情 |
详情
|
(XIII) |
33547 |
1-[(1-methylethylidene)amino]-3-[(2-methyl-1H-indol-4-yl)oxy]-2-propanol
|
|
C15H20N2O2 |
详情 |
详情
|
(C) |
23199 |
2-Propanone; Acetone; beta-ketopropane; chevron acetone;propan-2-one; Dimethyl formaldehyde; Dimethyl ketone; dimethylketal; Ketone propane; Methyl ketone; Propanone; Pyroacetic acid; Pyroacetic ether |
67-64-1 |
C3H6O |
详情 | 详情
|
合成路线27
该中间体在本合成路线中的序号:
(A) The esterification of 5,8-dihydro-1-naphthol (I) with acetic anhydride gives the corresponding acetate (II), which is oxidized with silver acetate and I2 in acetic acid to yield 2,3-cis-1,2,3,4-tetrahydro-2,3,5-naphthalenetriol (III). The treatment of this product with sodium methylate and epichlorhydrin (A) in methanol gives 2,3-cis-1,2,3,4-tetrahydro-5-(2,3-epoxypropoxy)-2,3-naphthalenediol (IV), which is finally treated with tertbutylamine (B) in chloroform-methanol.
【1】
Hanck, F.P.; et al.; Tetrahydronaphthyloxyaminopropanols and related compounds. CA 979926; DE 2258995; GB 1358722 .
|
【2】
Weetman, D.F.; Castaner, J.; Nadolol. Drugs Fut 1976, 1, 9, 434.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
40440 |
5,8-dihydro-1-naphthalenol
|
27673-48-9 |
C10H10O |
详情 | 详情
|
(II) |
40441 |
1-naphthyl acetate
|
830-81-9 |
C12H10O2 |
详情 | 详情
|
(III) |
40442 |
(6R,7S)-5,6,7,8-tetrahydro-1,6,7-naphthalenetriol
|
|
C10H12O3 |
详情 |
详情
|
(IV) |
40443 |
(2R,3S)-5-(2-oxiranylmethoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol
|
|
C13H16O4 |
详情 |
详情
|
合成路线28
该中间体在本合成路线中的序号:
(II) The reaction of 2-cyclopentylphenol (I) with epichlorhydrin (II) in a basic medium yields 1,2-epoxy-3-(2'-cyclopentylphenoxy)propane (III), which is the condensed with tert-butylamine (IV) in hot ethanol.
【1】
Ruschig, H.; et al.; ZA 6807915 .
|
【2】
Castaner, J.; Weetman, D.F.; Penbutolol. Drugs Fut 1976, 1, 10, 494.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
40452 |
2-cyclopentylphenol
|
|
C11H14O |
详情 |
详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
40453 |
2-cyclopentylphenyl 2-oxiranylmethyl ether; 2-[(2-cyclopentylphenoxy)methyl]oxirane
|
28163-40-8 |
C14H18O2 |
详情 | 详情
|
(IV) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线29
该中间体在本合成路线中的序号:
(IV) The condensation of 3-acetyl-4-hydroxyaniline (I) with N,N-diethylcarbamoyl chloride (II) in pyridine gives the urea (II), which is treated with epichlorohydrin (IV) and NaOH to yield N-[3-acetyl-4-(2,3-epoxypropoxy)phenyl]-N',N'-diethylurea (V). Finally, the epoxy ring of (V) is opened with tert-butylamine (VI).
【1】
Stormann-Menninger-Lerchenthal, H.; Pittner, H.; Zolss, G. (CL Pharma); 4-Ureido-2-acyl phenoxypropanolamine. DE 2458624; US 4034009 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
33815 |
1-(5-amino-2-hydroxyphenyl)-1-ethanone
|
|
C8H9NO2 |
详情 |
详情
|
(II) |
33816 |
N,N'-Diethylcarbamoyl chloride; 1-[(chlorocarbonyl)(ethyl)amino]ethane
|
88-10-8 |
C5H10ClNO |
详情 | 详情
|
(III) |
33817 |
N'-(3-acetyl-4-hydroxyphenyl)-N,N-diethylurea
|
|
C13H18N2O3 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
33818 |
N'-[3-acetyl-4-(2-oxiranylmethoxy)phenyl]-N,N-diethylurea
|
|
C16H22N2O4 |
详情 |
详情
|
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线30
该中间体在本合成路线中的序号:
(IV) The reaction of 4-nitrophenol (I) with acetic anhydride in aqueous NaOH gives the corresponding acetate (II), which is submitted to a Fries migration with AlCl3 in nitrobenzene at 140 C to yield the acetophenone (III). The condensation of (III) with epichlorohydrin (IV) by means of K2CO3 affords the adduct (V), which is treated with tert-butylamine (VI) in water to obtain the aminoisopropanol derivative (VII). The reduction of the nitro group of (VII) with H2 over Pd/C in methanol gives the corresponding amino derivative (VIII), which is finally condensed with N,N-diethylcarbamoyl chloride (IX) by means of TEA in THF to yield the target urea.
【1】
Joshi, R.A.; et al.; A new and improved process for celiprolol hydrochloride. Org Process Res Dev 2001, 5, 2, 176.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11236 |
4-Nitrophenol; p-Nitrophenol
|
100-02-7 |
C6H5NO3 |
详情 | 详情
|
(II) |
50841 |
4-Nitrophenyl acetate; Acetic acid 4-nitrophenyl ester; p-Nitrophenyl acetate
|
830-03-5 |
C8H7NO4 |
详情 | 详情
|
(III) |
50842 |
1-(2-hydroxy-5-nitrophenyl)-1-ethanone
|
|
C8H7NO4 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
50843 |
1-[5-nitro-2-(2-oxiranylmethoxy)phenyl]-1-ethanone
|
|
C11H11NO5 |
详情 |
详情
|
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VII) |
50844 |
1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-nitrophenyl]-1-ethanone
|
|
C15H22N2O5 |
详情 |
详情
|
(VIII) |
33819 |
1-[5-amino-2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1-ethanone
|
|
C15H24N2O3 |
详情 |
详情
|
(IX) |
33816 |
N,N'-Diethylcarbamoyl chloride; 1-[(chlorocarbonyl)(ethyl)amino]ethane
|
88-10-8 |
C5H10ClNO |
详情 | 详情
|
合成路线31
该中间体在本合成路线中的序号:
(A) The condensation of beta-phenyl-2-hydroxypropiophenone sodium salt (I) with 1-chloro-2,3-epoxypropane (A) at 100 C yields beta-phenyl-2-(2',3'-epoxypropoxy)propiophenone (II). which is then treated with n-propylamine (B) also at 100 C.
【1】
Beck, O.A.; et al.; Einfluß des antiarrhythmikus propafenon auf die intrakardiale erregungsleitung. Z Kardiol 1975, 64, 731-740. |
【2】
Sauchse, R.; 2-Hydroxy-3-phenylpropiophenone derivatives. AT 308076B; BE 0785318; DE 2001431; FR 2144601; GB 1307455; NL 7208214 .
|
【3】
Prigge, E.; Hapke, H.J.; Zur Pharmakologie von 2'-[2-Hydroxy-3-(propylamino).propoxy]-3-phenylpropiophenon (Propafenon, SA79)-hydrochlorid. Arzneim-Forsch Drug Res 1976, 36, 10, 1849-57.
|
【4】
Castaner, J.; Bahring-Kuhmley, S.R.; Propafenone. Drugs Fut 1977, 2, 5, 325.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
23923 |
1-propanamine
|
107-10-8 |
C3H9N |
详情 | 详情
|
(I) |
33895 |
sodium 2-(3-phenylpropanoyl)benzenolate
|
|
C15H13NaO2 |
详情 |
详情
|
(II) |
24438 |
1-[2-(2-oxiranylmethoxy)phenyl]-3-phenyl-1-propanone
|
|
C18H18O3 |
详情 |
详情
|
合成路线32
该中间体在本合成路线中的序号:
(II) The reaction of phenylpiperazine (I) with epichlorhydrin (II) leads to 1-chloro-3-(1-phenyl-4-piperazinyl)-2-propanol. This intermediate is dehydrohalogenated to 1-(1-phenyl-4-piperazinyl)-2,3-epoxypropane (III) using sodium hydroxide. The epoxide is converted without further purification into the corresponding 4,5-dihydro-5-[(4-phenyl-1-piperazinyl)methyl]-2-oxazolamine (COR3224) by condensation with monosodium cyanamide salt in methanol, which permits the solubilization of all compounds. The amidine group of the oxazoline ring induces a tautomeric amino-imino equilibrium. For COR3224 it has been shown by X-ray crystallography that the amino form is preponderant in the free base, whereas the imino form predominates in salts.
【1】
Creuzet, M.-H.; Feniou, C.; Jarry, C.; Prat, G.; Pontagnier, H. (Societé Cortial SA); Novel 2-amino-5-aminomethyl-2-oxazolines. EP 0106776; FR 2546167 . |
【2】
D'Arnoux, C.; Panconi, E.; Descas, P.; Vaugien, B.; Lambrey, B.; Mosser, J.; Jarry, C.; Gomond, P.; Saudubray, F.; Roux, J.; COR3224. Drugs Fut 1991, 16, 10, 893.
|
【3】
Ouhabi, J.; Jarry, C.; Bosc, J.J.; Carpy, A.; Crystal and molecular structure of 5-(1-aryl-4-piperazino)-methyl-2-amino-2-oxazolines with antidepressant activity. Arch Pharm 1990, 323, 157-61.
|
【4】
Bosc, J.J.; Descas, P.; Carpy, A.; Panconi, E.; Jarry, C.; Synthesis and antidepressant activity of 5-(1-aryl-4-piperazino)methyl-2-amino-2-oxazolines. Eur J Med Chem 1992, 27, 5, 437.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10756 |
N-Phenylpiperazine; 1-Phenylpiperazine; Phenyl piperazine
|
92-54-6 |
C10H14N2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
10758 |
1-Chloro-3-(4-phenylpiperazino)-2-propanol
|
|
C13H19ClN2O |
详情 |
详情
|
合成路线33
该中间体在本合成路线中的序号:
(II) The reaction of 1-naphthol (I) with epichlorohydrin (II) in the presence of aqueous sodium hydroxide yields 1-(1-naphthyloxy)-2,3-epoxypropane (III). (III) is then reacted either in alcohol or without any solvent with 1-(2-methoxyphenyl)piperazine (IV).
【1】
Thiel, M.; Sponer, G.; Stach, K.; Witte, E.-C.; Roesch, E. (Roche Diagnostics GmbH); 1-[3-(Napht-1-yloxy)-2-hydroxypropyl]-piperazine c. GB 1445548; US 3997666 .
|
【2】
Prous, J.; Castaner, J.; Naftopidil. Drugs Fut 1987, 12, 1, 31.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22935 |
alpha-naphthol; 1-naphthol
|
90-15-3 |
C10H8O |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
22937 |
2-[(1-naphthyloxy)methyl]oxirane; 1-naphthyl 2-oxiranylmethyl ether
|
|
C13H12O2 |
详情 |
详情
|
(IV) |
11882 |
1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine
|
35386-24-4 |
C11H16N2O |
详情 | 详情
|
合成路线34
该中间体在本合成路线中的序号:
(III) The reaction of 4-tert-butylbenzyl chloride (I) with Mg in ether gives the corresponding Grignard reagent (II), which is condensed with epichlorohydrin (III) yielding 4-(4-tert-butylphenyl)-1,2-epoxybutane (IV). The condensation of (IV) with methyl 4-hydroxybenzoate (V) by means of KOH in refluxing methanol affords 4-[4-(4-tert-butylphenyl)-2-hydroxybutoxy]benzoic acid methyl ester (VI), which is finally saponified with KOH in refluxing ethanol/water.
【1】
Rabasseda, X.; Castaner, J.; Mealy, N.; Lifibrol. Drugs Fut 1995, 20, 4, 325.
|
【2】
Grill, H.; Reiter, F.; Loser, R.; Schliack, M.; Seibel, K. (Klinge Pharma GmbH); p-Oxybenzoic acid derivs., as well as process for their preparation and their use as medicines. DE 3326164; EP 0133935; US 4582857 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10885 |
1-(tert-Butyl)-4-(chloromethyl)benzene; 1-Chloromethyl-4-tert-butyl benzene; 4-tert-Butylbenzyl chloride
|
19692-45-6 |
C11H15Cl |
详情 | 详情
|
(II) |
10886 |
[4-(tert-Butyl)benzyl](chloro)magnesium
|
|
C11H15ClMg |
详情 |
详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
10888 |
2-[4-(tert-Butyl)phenethyl]oxirane
|
|
C14H20O |
详情 |
详情
|
(V) |
10251 |
methyl 4-hydroxybenzoate; Methyl p-hydroxybenzoate
|
99-76-3 |
C8H8O3 |
详情 | 详情
|
(VI) |
10890 |
methyl 4-[4-[4-(tert-butyl)phenyl]-2-hydroxybutoxy]benzoate
|
|
C22H28O4 |
详情 |
详情
|
合成路线35
该中间体在本合成路线中的序号:
(II) The title compound is prepared by condensation of the acetamido isophthalamide (I) with epichlorohydrin (II) in 2-methoxyethanol.
【1】
Wille, K.; Hansen, P.-E.; Holtermann, H. (Amersham plc); X-ray contrast agents. EP 0108638; US 5349085 .
|
【2】
Cockbain, J.; Malthe-Soerenssen, D.; Schelver Hyni, A.C.; Aabye, A.; Bjoersvik, H.R.; Brekke, G.; Sjoegren, C.E. (Amersham plc); Process for the production of iodinated organic X-ray contrast agents. WO 9823296 .
|
【3】
Skailes, H.J.; Homestad, O.M. (Amersham plc); Preparation of iodixanol. WO 0047549 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59311 |
5-(acetylamino)-N~1~,N~3~-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
|
|
C16H20I3N3O7 |
详情 |
详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
合成路线36
该中间体在本合成路线中的序号:
(III) In a different strategy, the acetamido isophthalamide (I) is treated with boric acid and KOH to form the cyclic diborate tripotassium salt (II). Subsequent condensation of (II) with epichlorohydrin (III) yields the dimeric adduct (IV). The borate groups of (IV) are finally removed upon quenching with diluted HCl.
【1】
Bjoersvik, H.-R.; et al.; A selective process for N-alkylation in competition with O-alkylation: Boric acid, borax, and metaborate as a cheap and effective protecting group applicable for industrial-scale synthetic processes. Org Process Res Dev 2001, 5, 5, 472. |
【2】
Priebe, H. (Amersham plc); An N-alkylation. GB 2331098 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59311 |
5-(acetylamino)-N~1~,N~3~-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
|
|
C16H20I3N3O7 |
详情 |
详情
|
(II) |
59314 |
|
|
C16H19B2I3K3N3O11 |
详情 |
详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
59315 |
|
|
C35H44B4I6K4N6O23 |
详情 |
详情
|
合成路线37
该中间体在本合成路线中的序号:
(I) The reaction of epichlorohydrin (I) with benzyl alcohol (II) by means of NaOH in water gives 1,3-di-O-benzylglycerol (III), which is condensed with paraformaldehyde by means of HCl in methylene chloride to yield 1,3-di-O-benzyl-2-O-(chloromethyl)glycerol (IV). Acetylation of (IV) with potassium acetate in acetone affords 1,3-di-O-benzyl-2-O-(acetoxymethyl)glycerol (V), which is condensed with diacetylguanine (VI) by means of p-toluenesulfonic acid in sulfolane giving N2-acetyl-9-[[1,3-bis(benzyloxy)-2-propoxy]methyl]guanine (VII). Finally, this compound is deprotected by a treatment with palladium hydroxide in refluxing cyclohexane.
【1】
Dvorak, C.A.; Matthews, T.R.; Martin, J.C.; Verheyden, P.H.; Smee, D.F.; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: A new potent and selective antiherpes agent. J Med Chem 1983, 26, 5, 759-761.
|
【2】
Galloway, K.S.; Radatus, B.K.; Kennell, W.L.; Smith, K.O.; Ogilvie, K.K.; A new nucleoside analog, 9-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl]guanine, highly active in vitro aganist herpes simplex virus types 1 and 2. Antimicrob Agents Chemother 1982, 22, 1, 55-61. |
【3】
Verheyden, J.P.; Martin, J.C. (Roche Bioscience); 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent. EP 0066208; JP 4217983; JP 57203086; US 4355032 .
|
【4】
Pento, J.T.; Serradell, M.N.; Castaner, J.; BIOLF-62. Drugs Fut 1985, 10, 5, 365.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
18710 |
Benzyl alcohol; Phenylmethanol
|
100-51-6 |
C7H8O |
详情 | 详情
|
(III) |
29159 |
1,3-bis(benzyloxy)-2-propanol
|
6972-79-8 |
C17H20O3 |
详情 | 详情
|
(IV) |
24432 |
1-[[3-(benzyloxy)-2-(chloromethoxy)propoxy]methyl]benzene
|
|
C18H21ClO3 |
详情 |
详情
|
(V) |
29160 |
[2-(benzyloxy)-1-[(benzyloxy)methyl]ethoxy]methyl acetate
|
|
C20H24O5 |
详情 |
详情
|
(VI) |
29161 |
N-(9-acetyl-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide; N2,9-Diacetylguanine
|
3056-33-5 |
C9H9N5O3 |
详情 | 详情
|
(VII) |
29162 |
N-[9-([2-(benzyloxy)-1-[(benzyloxy)methyl]ethoxy]methyl)-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide
|
|
C25H27N5O5 |
详情 |
详情
|
合成路线38
该中间体在本合成路线中的序号:
(II) The reaction of 5-hydroxy-7-tetralone (I) with epichlorohydrin (I) at reflux temperature gives 5-(3-chloro-2-hydroxypropoxy)-7-tetralone (III), which is then condensed with butylamine (IV) in refluxlng alcohol.
【1】
Shavel, J.Jr.; Farber, S. (Pfizer Inc.); 3,4-Dihydroxynaphtalenoneoxy-2-hydroxypropylamines. BE 0739195; DE 1948144; DE 1967162; FR 2018626; GB 1223527; JP 48043734B; US 3641152 .
|
【2】
Castaner, J.; Serradell, M.N.; Weetman, D.F.; Blancafort, P.; Levobunolol Hydrochloride. Drugs Fut 1983, 8, 9, 788.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31099 |
5-hydroxy-3,4-dihydro-1(2H)-naphthalenone
|
28315-93-7 |
C10H10O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
31100 |
5-(3-chloro-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone
|
|
C13H15ClO3 |
详情 |
详情
|
(IV) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线39
该中间体在本合成路线中的序号:
(A) It can be obtained in two different ways both starting from the sodium salt of 5-hydroxy-3,4-dihydro-1(2H)-naphthalenone (I):
1) Its condensation with epichlorhydrine (A) in ethanol gives 5-(2,3-epoxypropoxy)-3,4-dihydro-1(2H)-naphthalenone (II), which is then condensed with tert-butylamine (B) in refluxing ethanol.
2) Its condensation with 3-chloro-1,2-propanediol (C) gives 5-(2,3-dihydroxy-propoxy)-3,4-dihydro-1(2H)-naphthalenone (III), which is esterified with tosyl chloride to the sulfonic ester (IV), and finally condensed with tert-butylamine.
【1】
Merrill, E.J.; Synthesis of 14C-labeled Bunolol. J Pharm Sci 1971, 60, 10, 1589-91.
|
【2】
Castaner, J.; Arrigoni-Martelli, E.; Bunolol. Drugs Fut 1976, 1, 9, 403.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
40456 |
sodium 5-oxo-5,6,7,8-tetrahydro-1-naphthalenolate
|
|
C10H9NaO2 |
详情 |
详情
|
(II) |
40457 |
5-(2-oxiranylmethoxy)-3,4-dihydro-1(2H)-naphthalenone
|
|
C13H14O3 |
详情 |
详情
|
(III) |
40458 |
5-(2,3-dihydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone
|
|
C13H16O4 |
详情 |
详情
|
(IV) |
40459 |
2-hydroxy-3-[(5-oxo-5,6,7,8-tetrahydro-1-naphthalenyl)oxy]propyl 4-methylbenzenesulfonate
|
|
C20H22O6S |
详情 |
详情
|
(C) |
12975 |
3-Chloro-1,2-propanediol; Glycerol alpha-monochlorohydrin
|
96-24-2 |
C3H7ClO2 |
详情 | 详情
|
合成路线40
该中间体在本合成路线中的序号:
(A) Compound can be prepared in three different ways:
1) Condensation of 2,5-dichlorophenol (I) with epichlorohydrin (A) by means of NaOH in water to give 1-(2,5-dichlorophenoxy)-2,3-epoxypropane (II), which is then condensed again with tert-butylamine in refluxing ethanol. Finally, HCl in ethanol is added.
2) Condensation of (I) with epichlorohydrin (A) by means of pyridine gives 1-(2,5-dichlorophenoxy)-3-chloro-2-propanol (III), which is then condensed with tert-butylamine as before.
3) Condensation of (I) with 1-(tertbutylamino)-2,3-epoxypropane (B) or with 1-(tertbutylamino)-3-chloro-2-propanol (C) by means of NaOH in refluxing ethanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
33503 |
N-(tert-butyl)-N-(2-oxiranylmethyl)amine; 2-methyl-N-(2-oxiranylmethyl)-2-propanamine
|
|
C7H15NO |
详情 |
详情
|
(I) |
11953 |
2,5-Dichlorophenol
|
583-78-8 |
C6H4Cl2O |
详情 | 详情
|
(II) |
33501 |
2,5-dichlorophenyl 2-oxiranylmethyl ether; 2-[(2,5-dichlorophenoxy)methyl]oxirane
|
|
C9H8Cl2O2 |
详情 |
详情
|
(III) |
33502 |
1-chloro-3-(2,5-dichlorophenoxy)-2-propanol
|
|
C9H9Cl3O2 |
详情 |
详情
|
(C) |
31720 |
1-(tert-butylamino)-3-chloro-2-propanol
|
|
C7H16ClNO |
详情 |
详情
|
合成路线41
该中间体在本合成路线中的序号:
(V) By condensation of ethyl 8-propyl-7-hydroxy-4-oxo-4H-1-benzopyran-2-carboxylate (I) with 4-(2,3-epoxypropoxy)-3-propyl-2-hydroxyacetophenone (II) by means of benzyltrimethylammonium hydroxide in refluxing DMF, followed by hydrolysis with NaHCO3 in refluxing ethanol - water.
The starting compounds (I) and (II) are prepared as follows:
1) The condensation of 3-propyl-2,4-dihydroxyacetophenone (III) with diethyl oxalate (IV) by means of sodium ethoxide in refluxing ethanol gives (I).
2) The condensation of acetophenone (III) with 1-chloro-2,3-epoxypropane (V) by means of KOH in refluxing ethanol - water gives (II).
【1】
Pratt, A.D.; Bantick, J..; Lee, T.B.; Chamberlain, T.R.; Hardern, D.N.; Appleton, R.A.; Antagonits of slow reacting substance od anaphylaxis. Synthesis of a series of chromone-2-carboxylic acids. J Med Chem 1979, 20, 3, 371.
|
【2】
Augstein, J.; Lee, T.B.; Carter, D. (AstraZeneca plc); Chromone derivs.. FR 2147287 .
|
【3】
Augstein, J.; Carter, D.; Lee, T.B. (AstraZeneca plc); Chrome cpds. having SRS-A properties. US 3882148 .
|
【4】
Blancafort, P.; Castaner, J.; Sneddon, J.M.; Serradell, M.N.; FPL-55,712. Drugs Fut 1982, 7, 7, 472.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
37126 |
|
|
C10H18NO |
详情 |
详情
|
(I) |
37124 |
ethyl 7-hydroxy-4-oxo-8-propyl-4H-chromene-2-carboxylate
|
|
C15H16O5 |
详情 |
详情
|
(II) |
37125 |
1-[2-hydroxy-4-(2-oxiranylmethoxy)-3-propylphenyl]-1-ethanone
|
|
C14H18O4 |
详情 |
详情
|
(III) |
13137 |
2',4'-Dihydroxy-3'-propylacetophenone; 1-(2,4-Dihydroxy-3-propylphenyl)-1-ethanone
|
40786-69-4 |
C11H14O3 |
详情 | 详情
|
(IV) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(V) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
合成路线42
该中间体在本合成路线中的序号:
(III) The demethylation of 1-(4-methoxyphenyl)acetone (I) by means of AlCl3 gives the corresponding 4-hydroxy compound (III), which is condensed with epichlorohydrin (III), yielding the expected oxiranylmethyl ether (IV). The addition of 1-(2-methoxyphenyl)piperazine (V) to the epoxide ring of (IV) affords the isopropyl alcohol derivative (VI), which is condensed with dimethylformamide dimethylacetal (VII) to afford the dimethylaminobutenone (VIII). Finally, this compound is cyclized with 2-cyanoacetamide (IX) by means of sodium ethoxide, providing the target pyridone.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10038 |
4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone
|
122-84-9 |
C10H12O2 |
详情 | 详情
|
(II) |
43654 |
1-(4-hydroxyphenyl)acetone
|
|
C9H10O2 |
详情 |
详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
43655 |
1-[4-(2-oxiranylmethoxy)phenyl]acetone
|
|
C12H14O3 |
详情 |
详情
|
(V) |
11882 |
1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine
|
35386-24-4 |
C11H16N2O |
详情 | 详情
|
(VI) |
43656 |
1-(4-[2-hydroxy-3-[4-(2-methoxyphenyl)-1-piperazinyl]propoxy]phenyl)acetone
|
|
C23H30N2O4 |
详情 |
详情
|
(VII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(VIII) |
43657 |
(Z)-4-(dimethylamino)-3-(4-[2-hydroxy-3-[4-(2-methoxyphenyl)-1-piperazinyl]propoxy]phenyl)-3-buten-2-one
|
|
C26H35N3O4 |
详情 |
详情
|
(IX) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
合成路线43
该中间体在本合成路线中的序号:
(II) The condensation of 2'-hydroxy-3-phenylpropiophenone (I) with 1 chloro-2,3-epoxypropane (II) by means of K2CO3 gives 2'-(2,3-epoxypropoxy)-3-phenylpropiophenone (III), which is then treated with 2-methyl-2-aminobutane (IV) in refluxing methanol.
【1】
Petrik, G.; Sachse, R. (Helopharm KG); 2-[2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy]-beta-phenylpropiophenone, its physiologically acceptable acid addition salts, and pharmaceutical compsns.. DE 3133814; US 4460605 .
|
【2】
Prous, J.; Castaner, J.; Difrafenone. Drugs Fut 1986, 11, 8, 645.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24436 |
1-(2-hydroxyphenyl)-3-phenyl-1-propanone
|
42772-82-7 |
C15H14O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
24438 |
1-[2-(2-oxiranylmethoxy)phenyl]-3-phenyl-1-propanone
|
|
C18H18O3 |
详情 |
详情
|
(IV) |
24439 |
2-methyl-2-butanamine
|
594-39-8 |
C5H13N |
详情 | 详情
|
合成路线44
该中间体在本合成路线中的序号:
(B) The nitration of 8-hydroxy-3,4-dihydrocarbostyril (I) with HNO3 in acetic acid-acetic anhydride gives 5-nitro-8-hydroxy-3,4-dihydrocarbostyril (II), which is reduced with SnCl2 in concentrated HCl yielding 5-amino-8-hydroxy-3,4-dihydrocarbostyril (III). The oxidation of (III) with FeCl3 in aqueous HCl affords 5,8-dioxo-3,4,5,8-tetrahydrocarbostyril (IV), which by treatment with SO2 in water is converted into 5,8-dihydroxy-3,4-dihydrocarbostyril (V). The treatment of (V) with benzyl chloride (A) and potassium carbonate in acetone gives 5-hydroxy-8-benzyloxy-3,4-dihydrocarbostyril (VII), which by reaction with epichlorohydrin (B) by means of piperidine affords 8-benzyloxy-5-(2,3-epoxypropoxy)-3,4-dihydrocarbostyril (VII). The opening of the epoxide ring of (VII) with tert-butylamine (C) in methanol yields 8-benzyloxy-5-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril (VIII) (1,2), which is finally hydrogenated with H2 over Pd/C.
【1】
Castaner, J.; Blancafort, P.; Serradell, M.N.; 8-Hydroxycarteolol. Drugs Fut 1980, 5, 2, 78.
|
【2】
Uchida, M.; et al.; Synthesis of 5-(3-tert-butylamino-2-hydroxypropxy)-8-3,4-dihydrocarbostyril hydochloride and its beta-adrenergic blocking agent. Yakugaku Zasshi 1976, 96, 5, 571-577.
|
【3】
Nakagawa, K.; et al.; US 4072683 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(A) |
19171 |
1-(Chloromethyl)benzene; Benzyl chloride
|
100-44-7 |
C7H7Cl |
详情 | 详情
|
(I) |
39062 |
8-hydroxy-3,4-dihydro-2(1H)-quinolinone
|
22246-18-0 |
C9H9NO2 |
详情 | 详情
|
(II) |
39063 |
8-hydroxy-5-nitro-3,4-dihydro-2(1H)-quinolinone
|
|
C9H8N2O4 |
详情 |
详情
|
(III) |
39064 |
5-amino-8-hydroxy-3,4-dihydro-2(1H)-quinolinone
|
|
C9H10N2O2 |
详情 |
详情
|
(IV) |
39065 |
3,4,4a,8a-tetrahydro-2,5,8(1H)-quinolinetrione
|
|
C9H9NO3 |
详情 |
详情
|
(V) |
39066 |
5,8-dihydroxy-3,4-dihydro-2(1H)-quinolinone
|
|
C9H9NO3 |
详情 |
详情
|
(VI) |
39067 |
8-(benzyloxy)-5-hydroxy-3,4-dihydro-2(1H)-quinolinone
|
|
C16H15NO3 |
详情 |
详情
|
(VII) |
39068 |
8-(benzyloxy)-5-(2-oxiranylmethoxy)-3,4-dihydro-2(1H)-quinolinone
|
|
C19H19NO4 |
详情 |
详情
|
(VIII) |
39069 |
8-(benzyloxy)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone
|
|
C23H30N2O4 |
详情 |
详情
|
(C) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线45
该中间体在本合成路线中的序号:
(III) A synthesis of (+)-(R)-flesinoxan has been described:
The nitration of pyrocatechol (I) with nitric acid gives 3-nitrocatechol (II), which is cyclized with epichlorohydrin (III) and acylated with acetic anhydride, yielding 2-(acetoxymethyl)-5-nitro-1,4-benzodioxan (IV). The reduction of (IV) with H2 over Pd/C in ethanol affords the corresponding amine (V), which is cyclized with bis(2-chloroethyl)amine in refluxing chlorobenzene to afford the piperazine (VI). The reaction of (VI) with N-(4-fluorobenzoyl)aziridine (VII) by means of triethylamine in refluxing acetone gives racemic flesinoxan (VIII), which is then submitted to a carefully controlled enzymatic acetylation with Amano P-30 lipase, which acetylates the (R)-isomer selectively. After separation of the nonesterified compound, the acetate is hydrolyzed to give an enriched product, which is submitted to a new enzymatic esterification to improve the optical purity.
【1】
Ghazal, N.B.; Ennis, M.D.; The synthesis of (+)- and (-)-flesinoxan: Application of enzymatic
resolution methodology. Tetrahedron Lett 1992, 33, 42, 6287.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11599 |
o-Dihydroxybenzene; Catechol; Pyrocatechol
|
120-80-9 |
C6H6O2 |
详情 | 详情
|
(II) |
11600 |
3-Nitro-1,2-benzenediol
|
|
C6H5NO4 |
详情 |
详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
11602 |
(5-nitro-2,3-dihydro-1,4-benzodioxin-2-yl)methyl acetate
|
|
C11H11NO6 |
详情 |
详情
|
(V) |
11603 |
(5-amino-2,3-dihydro-1,4-benzodioxin-2-yl)methyl acetate
|
|
C11H13NO4 |
详情 |
详情
|
(VI) |
11604 |
(5-piperazino-2,3-dihydro-1,4-benzodioxin-2-yl)methyl acetate
|
|
C15H20N2O4 |
详情 |
详情
|
(VII) |
11605 |
1-Aziranyl(4-fluorophenyl)methanone
|
|
C9H8FNO |
详情 |
详情
|
(VIII) |
11606 |
4-fluoro-N-(2-[4-[2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-5-yl]piperazino]ethyl)benzamide
|
|
C22H26FN3O4 |
详情 |
详情
|
合成路线46
该中间体在本合成路线中的序号:
(IX) Flesinoxan hydrochloride is obtained in a multiple-step synthesis, including the resolution of one of the racemic intermediates (VIII), starting with the monobenzyl ether of catechol (I).
Treatment of (I) with sulfuryl chloride in methylene chloride gives (II). This chloro compound is nitrated with nitric acid resulting in the mononitro derivative (III). In a one-pot procedure compound (III) is converted to the racemic benzodioxan structure (V) by condensation with epichlorohydrin, followed by treatment of the intermediate (IV) with hydrochloric acid and with potassium hydroxide, respectively. After conversion of the hydroxymethyl derivative to the benzoic ester (VI), compound (VII) can be obtained by catalytic hydrogenation of (VI). Treatment of (VII) with bischloroethylamine results in the racemic piperazine analogue (VIII). In this phase the resolution of the piperazine is carried out with (+)-camphorsulfonic acid. After several recrystallizations, the optically pure (+)-enantiomer is obtained. Reaction of this (+)-N-[2-(hydroxymethyl)-1,4-benzodioxan-5-yl]piperazine (VIII) with N-(4-fluorobenzoyl)aziridine, saponification of the benzoate ester and treatment with hydrochloric acid gives flesinoxan monohydrochloride.
【1】
Hartog, J.; Wouters, W.; FLESINOXAN HYDROCHLORIDE < Rec INN >. Drugs Fut 1988, 13, 1, 31.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15209 |
Phenol, 2-(phenylmethoxy)-; 2-(benzyloxy)phenol
|
6272-38-4 |
C13H12O2 |
详情 | 详情
|
(II) |
21575 |
2-(benzyloxy)-4-chlorophenol
|
|
C13H11ClO2 |
详情 |
详情
|
(III) |
21576 |
2-(benzyloxy)-4-chloro-6-nitrophenol
|
|
C13H10ClNO4 |
详情 |
详情
|
(IV) |
21577 |
2-[[2-(benzyloxy)-4-chloro-6-nitrophenoxy]methyl]oxirane; benzyl 5-chloro-3-nitro-2-(2-oxiranylmethoxy)phenyl ether
|
|
C16H14ClNO5 |
详情 |
详情
|
(V) |
21578 |
(7-chloro-5-nitro-2,3-dihydro-1,4-benzodioxin-2-yl)methanol
|
|
C9H8ClNO5 |
详情 |
详情
|
(VI) |
21579 |
(7-chloro-5-nitro-2,3-dihydro-1,4-benzodioxin-2-yl)methyl benzoate
|
|
C16H12ClNO6 |
详情 |
详情
|
(VII) |
21580 |
(5-amino-2,3-dihydro-1,4-benzodioxin-2-yl)methyl benzoate
|
|
C16H15NO4 |
详情 |
详情
|
(VIII) |
21581 |
[5-(1-piperazinyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl benzoate
|
|
C20H22N2O4 |
详情 |
详情
|
(IX) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(X) |
21583 |
2-chloro-N-(2-chloroethyl)-1-ethanamine; Bis(2-chloroethyl)amine; 1,1'-iminobis(2-chloroethane); N,N-bis(2-chloroethyl)amine
|
821-48-7 |
C4H9Cl2N |
详情 | 详情
|
合成路线47
该中间体在本合成路线中的序号:
(V) This compound has been obtained by two related ways:
1) The reaction of phenol (I) with formaldehyde gives 4-(hydroxymethyl)phenol (II), which is treated with NaCN in hot DMF to yield 2-(4-hydroxyphenyl)acetonitrile (III). The hydrolysis of (III) in refluxing ethanol/water, catalyzed by a Pt catalyst affords the corresponding acetamide (IV), which is condensed with an excess of hot epichlorohydrin (V) by means of piperidine gives 2-[4-(2-oxiranylmethoxy)phenyl]acetamide (VI). Finally, the oxirane ring of (VI) is opened with isopropylamine in methanol.
2)The condensation of acetonitrile (III) with epichlorohydrin (V) as before gives the 2-[4-(2-oxiranylmethoxy)phenyl]acetonitrile (VIII), which is treated with isopropylamine (VII) in methanol yielding 2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetonitrile (IX). Finally, this compound is hydrolyzed with refluxing ethanol/water catalyzed by a Pt catalyst as before to afford the target acetamide.
【1】
Akisanya, J.; et al.; A synthesis of atenolol using a nitrile hydration catalyst. Org Process Res Dev 1998, 2, 4, 274.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(II) |
29474 |
4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol
4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol
|
623-05-2 |
C7H8O2 |
详情 | 详情
|
(III) |
32753 |
2-(4-hydroxyphenyl)acetonitrile; 4-Hydroxybenzyl cyanide
|
14191-95-8 |
C8H7NO |
详情 | 详情
|
(IV) |
32754 |
p-Hydroxyphenylacetamide; 2-(4-hydroxyphenyl)acetamide; 4-Hydroxybenzeneacetamide; 4-Hydroxyphenylacetamide
|
17194-82-0 |
C8H9NO2 |
详情 | 详情
|
(V) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(VI) |
32755 |
2-[4-(2-oxiranylmethoxy)phenyl]acetamide
|
|
C11H13NO3 |
详情 |
详情
|
(VII) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
(VIII) |
32756 |
2-[4-(2-oxiranylmethoxy)phenyl]acetonitrile
|
|
C11H11NO2 |
详情 |
详情
|
(IX) |
32757 |
2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetonitrile
|
|
C14H20N2O2 |
详情 |
详情
|
合成路线48
该中间体在本合成路线中的序号:
(II) Prepared in two steps by condensation of p-hydroxyphenylacetamide (I) and epichlorhydrine (II) with piperidine as catalyst, giving 1-(p-carbamoylmethylphenoxy)-2,3-epoxypropane (III), m.p. 158-60 C, followed by reaction of the epoxy ring with isopropylamine (IV).
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32754 |
p-Hydroxyphenylacetamide; 2-(4-hydroxyphenyl)acetamide; 4-Hydroxybenzeneacetamide; 4-Hydroxyphenylacetamide
|
17194-82-0 |
C8H9NO2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
32755 |
2-[4-(2-oxiranylmethoxy)phenyl]acetamide
|
|
C11H13NO3 |
详情 |
详情
|
(IV) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线49
该中间体在本合成路线中的序号:
(IV) The synthesis of the optical enantiomers of mosapride has been described:
The reductocondensation of 4-fluorobenzaldehyde (I) with ethanolamine (II) by means of NaBH4 and NaHCO3 in refluxing methanol gives 2-(4-fluorobenzylamino)ethanol (III), which is condensed with epichlorohydrin (IV) to yield the diol (V). Compound (V), without isolation, is cyclized with conc. H2SO4 to afford 2-(chloromethyl)-4-(4-fluorobenzyl)morpholine (VI), which is treated with refluxing water-formamide to afford the corresponding methanol derivative (VII). Tosylation of (VII) with tosyl chloride and triethylamine/4-(dimethylamino)pyridine in dichloromethane gives the tosylate (VIII) as a racemic mixture. The optical resolution of (VIII) with N-(p-toluenesulfonyl)-L-glutamic acid in methanol affords the (S)-tosylate [(S)-IX] and the (R)-tosylate [(R)-IX]. The reaction of both [(S)-IX] and [(R)-IX] with sodium azide followed by reduction with bis(2-methoxyethoxy)aluminum hydride (vitride) gives the chiral amines [(S)-X] and [(R)-X], which are finally condensed with 4-amino-5-chloro-2-ethoxybenzoic acid (XI) by means of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (WSC) in dichloromethane, yielding the (S)- and (R)-enantiomers of mosapride.
【1】
Morie, T.; Kato, S.; Harada, H.; Yoshida, N.; Matsumoto, J.; Synthesis and biological activities of the optical isomers of (±)-4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide (mosapride). Chem Pharm Bull 1994, 42, 4, 877. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
((S)-IX) |
12345 |
[(2S)-4-(4-fluorobenzyl)-1,4-oxazinan-2-yl]methyl phenylmethanesulfonate
|
|
C19H22FNO4S |
详情 |
详情
|
((R)-IX) |
12346 |
[(2R)-4-(4-fluorobenzyl)-1,4-oxazinan-2-yl]methyl phenylmethanesulfonate
|
|
C19H22FNO4S |
详情 |
详情
|
((R)-X) |
12347 |
[(2R)-4-(4-Fluorobenzyl)morpholinyl]methanamine; [(2R)-4-(4-Fluorobenzyl)morpholinyl]methylamine
|
|
C12H17FN2O |
详情 |
详情
|
((S)-X) |
12348 |
[(2S)-4-(4-Fluorobenzyl)-1,4-oxazinan-2-yl]methylamine; [(2S)-4-(4-Fluorobenzyl)-1,4-oxazinan-2-yl]methanamine
|
|
C12H17FN2O |
详情 |
详情
|
(I) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(II) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(III) |
12334 |
2-[(4-Fluorobenzyl)amino]-1-ethanol
|
|
C9H12FNO |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
12341 |
1-Chloro-3-[(4-fluorobenzyl)(2-hydroxyethyl)amino]-2-propanol
|
|
C12H17ClFNO2 |
详情 |
详情
|
(VI) |
12342 |
2-(Chloromethyl)-4-(4-fluorobenzyl)morpholine
|
|
C12H15ClFNO |
详情 |
详情
|
(VII) |
12343 |
[4-(4-Fluorobenzyl)-2-morpholinyl]methanol
|
|
C12H16FNO2 |
详情 |
详情
|
(VIII) |
12344 |
[4-(4-fluorobenzyl)-2-morpholinyl]methyl 4-methylbenzenesulfonate
|
|
C19H22FNO4S |
详情 |
详情
|
(XI) |
12333 |
4-Amino-5-chloro-2-ethoxybenzoic acid
|
|
C9H10ClNO3 |
详情 |
详情
|
合成路线50
该中间体在本合成路线中的序号:
(I) This compound can be obtained in a simple way:
Under nitrogen, borontrifluoride etherate solution is added to heated 2-methyl-1-propanol (II), and 1-chloro-2,3-epoxypropane (I) is added. When the reaction is completed, pyrrolidine (IV) is added to obtain alpha-[2-methyl-propoxymethyl]-1-pyrrolidine-ethanol (V). 1-[2-Chloro-3-(2-methylpropoxy)propyl]pyrrolidine (VI) is obtained by chlorination with thionyl chloride of the subsequent amino alcohol. The condensation of 1-propynyl-1-cyclohexanol (VII) with 1-[2-chloro-3-(2-methylpropoxy)propyl]pyrrolidine (VI) in toluene and sodium hydroxide in water affords dopropidil.
Due to the pyrrolidine shift mechanism, the reaction yields the correct structure, confirmed by 1H and 13C NMR as well as by mass spectra and X-ray analysis. The pyrrolidine shift mechanism is explained by the assumption of an intermediate aziridinium ion (VIII), which is opened regiospecifically at the less hindered C-N bond by the nucleophile ion.
【1】
Carlier, P.; Montell, A.J.-C.; Simond, J.A.L. (Riom Laboratoires); Ethers of 1-(2-propynyloxy)-2-amino-3-propanol, their preparation and their application in therapeutic. EP 0031771; US 4430332 .
|
【2】
Dupont, L.; Dideberg, O.; Simond, J.; X-ray analysis of CERM 4205. Acta Cryst Sect C 1986, 42, 864.
|
【3】
Massingham, R.; Monteil, A.; DOPROPIDIL HYDROCHLORIDE. Drugs Fut 1990, 15, 5, 453.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
12982 |
2-Methyl-1-propanol
|
78-83-1 |
C4H10O |
详情 | 详情
|
(III) |
12983 |
2-(Isobutoxymethyl)oxirane; Isobutyl 2-oxiranylmethyl ether
|
|
C7H14O2 |
详情 |
详情
|
(IV) |
11376 |
Pyrrolidine
|
123-75-1 |
C4H9N |
详情 | 详情
|
(V) |
12985 |
1-Isobutoxy-3-(1-pyrrolidinyl)-2-propanol
|
|
C11H23NO2 |
详情 |
详情
|
(VI) |
12986 |
2-Chloro-3-(1-pyrrolidinyl)propyl isobutyl ether; 1-(2-Chloro-3-isobutoxypropyl)pyrrolidine
|
|
C11H22ClNO |
详情 |
详情
|
(VII) |
12987 |
1-Propynyl-1-cyclohexanol; 1-(1-Propynyl)cyclohexanol
|
697-37-0 |
C9H14O |
详情 | 详情
|
(VIII) |
12988 |
1-(Isobutoxymethyl)-3-azoniaspiro[2.4]heptane
|
|
C11H22NO |
详情 |
详情
|
合成路线51
该中间体在本合成路线中的序号:
(XXI) Compound (XIX) reacts with 4-mercapto-N,N-bis(p-nitrobenzyloxycarbonyl)pyrazolidine (XX) in the presence of diisopropylethylamine to give p-nitrobenzyl (1R,5R,6S)-2-[[N,N-bis(p-nitrobenzyloxycarbonyl)pyrazolidin-4-yl]thio]-6-[1(R)-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate (XXIII).
Compound (XXIII) is reduced with H2 over Pd/C to give (1R,5R,6S)-2-[[N,N-bis(p-nitrobenzyloxycarbonyl)pyrazolidin-4-yl]thio]-6-[1(R)-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate (XXIV), which is finally reacted with ethylformimidate hydrochloride (XXV).
Compound (XX) is obtained from epichlorohydrin (XXI) by treatment with hydrazine monohydrate followed by reaction with p-nitrobenzyloxycarbonyl chloride to give 4-hydroxy-N,N-bis(p-nitrobenzyloxycarbonyl)pyrazolidine (XXII), which is subsequently treated with methanesulfonyl chloride and triethylamine in dichloromethane, potassium acetate in acetone and sodium methoxide in methanol-THF. Compound (XX) can also be obtained from hydrazine hydrate using a longer alternative procedure.
【1】
Kumagai, T.; Matsunaga, H.; Machida, Y.; Nagase, Y.; Hikida, M.; Nagao, Y. (Lederle (Japan), Ltd.); (1R,5S,6S)-2-(Substd. thio)-6-[(R)-1-hydroxy-ethyl]-1-methyl-carbapenem-3-carboxylic-acid derivatives. AU 8814428; EP 0289801; JP 1989025779; US 4925836 . |
【2】
Abe, T.; Matsunaga, H.; Kumagai, T.; Nagase, Y. (Lederle (Japan), Ltd.); Method of preparation of carbapenem cpds. JP 1990088578 .
|
【3】
Hayashi, T.; Shimada, O.; Inoue, Y.; Nagao, Y.; Matsunaga, H.; Nagase, Y.; Kumagai, T.; Abe, T.; beta-Lactams. 3. Asymmetric total synthesis of new non-natural 1beta-methylcarbapenems exhibiting strong antimicrobial activities and stability against human renal dehydropeptidase-. J Org Chem 1992, 57, 15, 4243-9. |
【4】
Rabasseda, X.; Prous, J.; Castaner, J.; Biapenem. Drugs Fut 1994, 19, 7, 631.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIX) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XX) |
13208 |
bis(4-nitrobenzyl) 4-sulfanyl-1,2-pyrazolidinedicarboxylate
|
|
C19H18N4O8S |
详情 |
详情
|
(XXI) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(XXII) |
13210 |
bis(4-nitrobenzyl) 4-hydroxy-1,2-pyrazolidinedicarboxylate
|
|
C19H18N4O9 |
详情 |
详情
|
(XXIII) |
13211 |
bis(4-nitrobenzyl) 4-([(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-2-[2-(4-nitrophenyl)acetyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]sulfanyl)-1,2-pyrazolidinedicarboxylate
|
|
C36H34N6O13S |
详情 |
详情
|
(XXIV) |
13212 |
(4R,5S,6S)-3-[(1,2-bis[[(4-Nitrobenzyl)oxy]carbonyl]-4-pyrazolidinyl)sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
|
|
C29H29N5O12S |
详情 |
详情
|
(XXV) |
13213 |
ethyl iminoformate
|
|
C3H7NO |
详情 |
详情
|
合成路线52
该中间体在本合成路线中的序号:
(IV) The formylation of 5-hydroxy-1,2,3,4-tetrahydroisoquinoline (I) with formamide (II) at 140 C gives N-formyl-5-hydroxy-1,2,3,4-tetrahydroisoquinoline (III), which is condensed with epichlorohydrin (IV) by means of NaOH in water yielding N-formyl-5-(2,3-epoxypropoxy)-1,2,3,4-tetrahydroisoquinoline (V). Finally, this compound is condensed with tert-butylamine (VI).
【1】
Knoll, A.-G. (Knoll AG); Isoquinoline derivatives. NL 7513301 .
|
【2】
Westermann, A.; Zimmermann, F.; Wuppermann, D.; Friedrich, L.; Raschack, M. (Knoll AG.); New isoquinoline derivatives. DE 2620179 .
|
【3】
Prous, J.; Castaner, J.; SOQUINOLOL MUCATE < Rec INNM >. Drugs Fut 1989, 14, 5, 439.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20879 |
1,2,3,4-tetrahydro-5-isoquinolinol
|
|
C9H11NO |
详情 |
详情
|
(III) |
20880 |
5-hydroxy-3,4-dihydro-2(1H)-isoquinolinecarbaldehyde
|
|
C10H11NO2 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
20882 |
5-(2-oxiranylmethoxy)-3,4-dihydro-2(1H)-isoquinolinecarbaldehyde
|
|
C13H15NO3 |
详情 |
详情
|
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线53
该中间体在本合成路线中的序号:
(I) The reaction of 2-hydroxy-3'-methoxybibenzyl (I) with epichlorohydrin (II) by means of NaH in DMF gives 2-(2,3-epoxypropoxy)-3'-methoxybibenzyl (III), which by reaction with dimethylamine in refluxing THF yields 2-[3-(dimethylamino)-2-hydroxypropoxy]-3'-methoxybibenzyl (IV). Finally, this compound is treated with succinic anhydride (V) in refluxing THF and with HCl in acetone.
【1】
Kikumoto, R.; Fukami, H.; Hara, H.; Ninomiya, K.; Sugano, M. (Mitsubishi Chemical Corp.); Pharmaceutically active (3-aminopropoxy)-bibenzyl derivs. EP 0072942 .
|
【2】
Prous, J.; Castaner, J.; Sarpogrelate Hydrochloride. Drugs Fut 1992, 17, 12, 1093.
|
【3】
Osakabe, M.; Fukami, H.; Sugano, M.; Kikumoto, R.; Ninomiya, K.; Tamao, Y.; Hara, H.; Syntheses and platelet aggregation inhibitory and antithrombotic properties of [2-[(omega-aminoalkoxy)phenyl]ethyl]benzenes. J Med Chem 1990, 33, 6, 1818.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
13604 |
2-(3-Methoxyphenethyl)phenol
|
|
C15H16O2 |
详情 |
详情
|
(III) |
13605 |
2-(3-Methoxyphenethyl)phenyl 2-oxiranylmethyl ether; 2-[[2-(3-Methoxyphenethyl)phenoxy]methyl]oxirane
|
|
C18H20O3 |
详情 |
详情
|
(IV) |
13606 |
1-(Dimethylamino)-3-[2-(3-methoxyphenethyl)phenoxy]-2-propanol
|
|
C20H27NO3 |
详情 |
详情
|
(V) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
合成路线54
该中间体在本合成路线中的序号:
6-Hydroxy-2(1H)-quinolinone (I) is alkylated with epichlorohydrin in the presence of K2CO3 in MeOH to afford 6-(2,3-epoxypropoxy)-2(1H)-quinolinone (II). Ring opening of the epoxide (II) with 3,4-dimethoxybenzylamine gives OPC-18790.
This compound is also obtained by the reductive alkylation of 6-(3-amino-2-hydroxypropoxy)-2(1H)-quinolinone (III) with 3,4-dimethoxybenzaldehyde.
【1】
Sumida, T.; Fujioka, T.; Teramoto, S.; Tominaga, M.; Yabuuchi, Y.; Mori, T.; Hosokawa, T.; Novel positive inotropic agents; synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2(1H)-quinolinone derivatives. J Med Chem 1992, 35, 20, 3607-12. |
【2】
Fujioka, T.; OPC-18790. Drugs Fut 1993, 18, 12, 1114.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
|
13920 |
(3,4-Dimethoxyphenyl)methanamine; 3,4-Dimethoxybenzylamine; Veratrylamine
|
5763-61-1 |
C9H13NO2 |
详情 | 详情
|
|
18304 |
3,4-Dimethoxybenzaldehyde; Veratraldehyde
|
120-14-9 |
C9H10O3 |
详情 | 详情
|
(I) |
13913 |
6-Hydroxy-2(1H)-quinolinone
|
|
C9H7NO2 |
详情 |
详情
|
(II) |
13914 |
6-(2-Oxiranylmethoxy)-2(1H)-quinolinone
|
|
C12H11NO3 |
详情 |
详情
|
(III) |
13915 |
6-(3-Amino-2-hydroxypropoxy)-2(1H)-quinolinone
|
|
C12H14N2O3 |
详情 |
详情
|
合成路线55
该中间体在本合成路线中的序号:
2,4-Dihydroxyacetophenone (I) is formed by the Friedel-Crafts acetylation of resorcinol. This compound is condensed with diethyl oxalate in sodium ethoxide solution, affording (II). Disodium cromproxate (IV) is conveniently prepared from (II) by treatment with epichlorohydrine in aqueous ethanolic alkaline solution. It is recrystallized from hot water.
【1】
Ruyun, J.; Disodium Cromproxate. Drugs Fut 1991, 16, 5, 422.
|
【2】
Liang, X.; Qi, J.; Lu, Y.; A simplified synthesis of 1,3-bis-(2-carboxychromone-7-oxy)-2-hydroxypropane disodium salt (78012). Acta Pharm Sin 1982, 17, 2, 143-5.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
|
10361 |
1,3-Dihydroxybenzene; m-Dihydroxybenzene; Resorcinol; Resorcin; 1,3-Benzenediol
|
108-46-3 |
C6H6O2 |
详情 | 详情
|
(I) |
13961 |
Resacetophenone; 1-(2,4-Dihydroxyphenyl)-1-ethanone
|
89-84-9 |
C8H8O3 |
详情 | 详情
|
(II) |
13962 |
ethyl 7-hydroxy-4-oxo-4H-chromene-2-carboxylate
|
|
C12H10O5 |
详情 |
详情
|
(III) |
13963 |
ethyl 7-(3-[[2-(ethoxycarbonyl)-4-oxo-4H-chromen-7-yl]oxy]-2-hydroxypropoxy)-4-oxo-4H-chromene-2-carboxylate
|
|
C27H24O11 |
详情 |
详情
|
合成路线56
该中间体在本合成路线中的序号:
(II) The condensation of 4-[2-(cyclopropylmethoxy)ethyl]phenol (I) with epichlorohydrin (II) in pyridine gives the phenol ether (III), which is treated with HCl to open the epoxide ring and yield the racemic chloropropanol (IV). The optical resolution of (IV) by means of Lipase SP 435-L or AK and vinyl acetate (V) gives a mixture of (S)-acetate (S)-(VI) and unreacted (R)-alcohol (R)-(VI) that is easily separated. Finally, the chiral chloropropanol (R)-(VI) is treated with isopropylamine (VII) to afford the target betaxolol.
The optical resolution of racemic betaxolol by means of the previously mentioned lipases has also been tried with poor results.
【1】
Di Bono, G.; Scilimati, A.; Synthesis 1995, 6, 688.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
33330 |
4-[2-(Cyclopropylmethoxy)ethyl]phenol; p-(Cyclopropylmethoxyethyl)phenol
|
|
C12H16O2 |
详情 |
详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
33331 |
2-([4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl)oxirane; 1-[p-(Cyclopropylmethoxyethyl)phenoxy]-2,3-epoxypropane; 4-[2-(Cyclopropylmethoxy)ethyl]phenyl 2-oxiranylmethyl ether
|
|
C15H20O3 |
详情 |
详情
|
(IV) |
55675 |
1-chloro-3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2-propanol
|
|
C15H21ClO3 |
详情 |
详情
|
(V) |
24543 |
vinyl acetate
|
108-05-4 |
C4H6O2 |
详情 | 详情
|
(VI) |
55676 |
(2R)-1-chloro-3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2-propanol
|
|
C15H21ClO3 |
详情 |
详情
|
(VII) |
55676 |
(2R)-1-chloro-3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2-propanol
|
|
C15H21ClO3 |
详情 |
详情
|
(VIII) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线57
该中间体在本合成路线中的序号:
(II) MCI-196 is synthesized by condensation of 2-methylimidazole (I) with epichlorohydrin (II) as follows:
Equimolecular parts (0.5 M: 0.5 M) of (I) and (II) were allowed to condense in water (100 ml) at 90 C for 14 h; then 0.094 mol of (II) wa added and the reaction continued for 2 h at 45 C. The resulting resin was treated with 0.094 M of a 20% aqueous solution of NaOH and heated at 45 C for 2 h more. Finally, heat curing of the resin at 120 C for 5 h was performed. The resin was isolated by precipitation with water.
【1】
Toda, H. (Mitsubishi Chemical Corp.); Process for the preparation of granular basic ion exchange resins. JP 1985245626 .
|
【2】
Nomura, T.; Hamada, Y.; Kurihara, Y. (Mitsubishi Chemical Corp.); Oral hypocholesterolemic agents. JP 1992013627 .
|
【3】
Nomura, T.; Hamada, Y.; Kurihara, Y. (Mitsubishi Chemical Corp.); Oral hypocholesterolemic agents. JP 1990124819 .
|
【4】
Toda, H.; Kihara, K. (Bristol-Myers Squibb Co.); Novel quaternary salt of polymer. BE 0898807; CH 663415; DE 3403125; GB 2134119; NL 8400237 .
|
【5】
Toda, H.; Kihara, K. (Mitsubishi Chemical Corp.); Improved preparation process for anion exchange resins. JP 1984155421 .
|
【6】
Toda, H.; Mizogami, S.; Kihara, K.; Hashimoto, M.; Bile acid binding and hypocholesterolemic activity of a new anion exchange resin from 2-methylimidazol and epichlorohydrin. J Pharm Sci 1988, 77, 6, 531.
|
【7】
Castaner, J.; Prous, J.; MCI-196. Drugs Fut 1993, 18, 1, 15.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15670 |
2-Methylimidazole; 2-Methyl-1H-imidazole
|
693-98-1 |
C4H6N2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
合成路线58
该中间体在本合成路线中的序号:
(V) N-(2,2-Diphenylacetyl)piperazine (IV) was prepared by acylation of N-formylpiperazine (II) with 2,2-diphenylacetyl chloride (I), followed by acid-promoted formyl deprotection of the resulting amide (III). Condensation of 5-hydroxyquinoline (VI) with epichlorohydrin (V) in the presence of potassium tert-butoxide in DMF at 90 C provided 5-(2,3-epoxypropoxy)quinoline (VII), which was subsequently coupled with acylpiperazine (IV) in boiling isopropanol to yield (VIII). This was finally treated with fumaric acid (IX) in MeOH to furnish the title sesquifumarate salt.
【1】
Suzuki, T.; et al.; Structure-activity relationship of newly synthesiz. J Med Chem 1997, 40, 13, 2047.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23800 |
Diphenylacetyl chloride; 2,2-diphenylacetyl chloride
|
1871-76-7 |
C14H11ClO |
详情 | 详情
|
(II) |
23801 |
1-piperazinecarbaldehyde; N-Formylpiperazine
|
7755-92-2 |
C5H10N2O |
详情 | 详情
|
(III) |
23802 |
4-(2,2-diphenylacetyl)-1-piperazinecarbaldehyde
|
|
C19H20N2O2 |
详情 |
详情
|
(IV) |
23803 |
2,2-diphenyl-1-(1-piperazinyl)-1-ethanone
|
|
C18H20N2O |
详情 |
详情
|
(V) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(VI) |
23805 |
5-quinolinol
|
578-67-6 |
C9H7NO |
详情 | 详情
|
(VII) |
23806 |
5-(2-oxiranylmethoxy)quinoline; 2-oxiranylmethyl 5-quinolinyl ether
|
|
C12H11NO2 |
详情 |
详情
|
(VIII) |
23807 |
1-[4-[2-hydroxy-3-(5-quinolinyloxy)propyl]-1-piperazinyl]-2,2-diphenyl-1-ethanone
|
|
C30H31N3O3 |
详情 |
详情
|
(IX) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线59
该中间体在本合成路线中的序号:
Proxodolol (V) was obtained as shown in Scheme 21696501a:
Monoalkylation of pyrocatechol with chloroacetic acid gives 2-hydroxyphenoxyacetic acid (I), which is cyclized on heating into 1,4-benzodioxan-2-one (II). Condensation of (II) with acetamidoxime, giving 2-methyl-5-(2-hydroxyphenoxymethyl)-1,2,4-oxadiazole (III), followed by alkylation with epichlorohydrin yields the corresponding diether (IV), which smoothly reacts with tert-BuNH2, and the amine (V) is converted into its hydrochloride by reaction with HCl.
【1】
Mashkovski, M.D.; Sokolov, S.D.; Vinogradova, S.M.; Yuzhakov, S.D.; Yermakova, V.N.; Proxodolol. Drugs Fut 1997, 22, 5, 499.
|
【2】
Sokolov, S.D.; Vinogradova, S.M.; Azarevich, O.G.; Berg, M.V.; Mashkovski, M.D.; Yuzhakov, S.D.; Morozov, A.V. (Center for Chemistry of Drugs); The hydrochlorides of derivs. of 5-phenoxymethyl-1,2, 4-oxadiaxole, possessing beta- and alpha-adrenoblocking activities. SU 1132505 . |
【3】
Sokolov, S.D.; Vinogradova, S.M.; Azarevich, O.G. (Center for Chemistry of Drugs); The method for producing of 5-(2-hydroxyphenoxymethyl)-1,2,4-oxadiazoles. SU 1139129 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
|
11599 |
o-Dihydroxybenzene; Catechol; Pyrocatechol
|
120-80-9 |
C6H6O2 |
详情 | 详情
|
|
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
|
64134 |
N'-hydroxyethanimidamide
|
|
C2H6N2O |
详情 |
详情
|
(I) |
16894 |
2-Hydroxyphenoxyacetic acid; o-Hydroxyphenoxyacetic acid; 2-(2-hydroxyphenoxy)acetic acid
|
6324-11-4 |
C8H8O4 |
详情 | 详情
|
(II) |
16895 |
1,4-BENZODIOXAN-2-ONE; 1,4-benzodioxin-2(3H)-one
|
4385-48-2 |
C8H6O3 |
详情 | 详情
|
(III) |
16896 |
2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenol
|
|
C10H10N2O3 |
详情 |
详情
|
(IV) |
16897 |
2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenyl 2-oxiranylmethyl ether; 3-methyl-5-[[2-(2-oxiranylmethoxy)phenoxy]methyl]-1,2,4-oxadiazole
|
|
C13H14N2O4 |
详情 |
详情
|
(V) |
16898 |
1-(tert-butylamino)-3-[2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenoxy]-2-propanol hydrochloride
|
|
C17H26ClN3O4 |
详情 |
详情
|
合成路线60
该中间体在本合成路线中的序号:
(II) The reaction of 4-fluorophenol (I) with epichlorohydrin (II) by means of K2CO3 in refluxing acetone gives 2-(4-fluorophenoxymethyl)oxirane (III), which is submitted to an enantioselective ring opening with the Jacobsen (R,R)-catalyst yielding a mixture of the (R)-diol (IV) and unaltered epoxide (V), easily separated by column chromatography. The reaction of (IV) with tosyl chloride and pyridine in dichloromethane affords the primary monotosylate (VI), which is converted into the chiral epoxide (VII) by reaction with NaH in THF/DMF. The reaction of (VII) with allylmagnesium bromide (VIII) in ethyl ether gives the 2-hexenol derivative (IX), which is treated with benzenesulfonyl chloride and DMAP yielding the sulfonate (X). The ozonolysis of (X) with ozone in dichloromethane affords the aldehyde (XI), which is condensed with ethoxycarbonylmethylene(triphenyl)phosphorane (XII) yielding the 2-heptenoic ester (XIII). The reduction of (XIII) with diisobutylaluminum hydride (DIBAL) in toluene/dichloromethane provides the 2-hepten-1-ol (XIV), which is epoxidized with cumene hydroperoxide in the presence of diisopropyl (+)-tartrate and Ti(Oi-Pr)4 in dichloromethane to give the chiral epoxyalcohol (XV). The reaction of (XV) with triphenylphosphine/CCl4 in chloroform affords the corresponding chloride (XVI).
【1】
Adhikari, S.S.; Hymavathi, L.; Sadalapure, K.; Sharma, G.V.M.; Sreenivas, P.; Mhaskar, S.V.; Lalitha, S.V.S.; Chorghade, M.S.; Murugaiah, A.M.S.; Prasad, T.R.; Reddy, B.S.; Gurjar, M.K.; Reddy, V.G.; Krishna, P.R. (LeukoSite, Inc.); Substd. oxygen alicyclic cpds., including methods for synthesis thereof. WO 0001381 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
14713 |
benzenesulfonyl chloride
|
98-09-9 |
C6H5ClO2S |
详情 | 详情
|
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
22150 |
2-[(4-fluorophenoxy)methyl]oxirane; 4-fluorophenyl 2-oxiranylmethyl ether
|
18123-82-5 |
C9H9FO2 |
详情 | 详情
|
(IV) |
32985 |
(2R)-3-(4-fluorophenoxy)-1,2-propanediol
|
|
C9H11FO3 |
详情 |
详情
|
(V) |
32986 |
4-fluorophenyl (2S)oxiranylmethyl ether; (2S)-2-[(4-fluorophenoxy)methyl]oxirane
|
108648-25-5 |
C9H9FO2 |
详情 | 详情
|
(VI) |
32987 |
(2S)-3-(4-fluorophenoxy)-2-hydroxypropyl 4-methylbenzenesulfonate
|
|
C16H17FO5S |
详情 |
详情
|
(VII) |
22150 |
2-[(4-fluorophenoxy)methyl]oxirane; 4-fluorophenyl 2-oxiranylmethyl ether
|
18123-82-5 |
C9H9FO2 |
详情 | 详情
|
(VIII) |
10386 |
Allyl(bromo)magnesium
|
1730-25-2 |
C3H5BrMg |
详情 | 详情
|
(IX) |
32988 |
(2R)-1-(4-fluorophenoxy)-5-hexen-2-ol
|
|
C12H15FO2 |
详情 |
详情
|
(X) |
32989 |
(1R)-1-[(4-fluorophenoxy)methyl]-4-pentenyl benzenesulfonate
|
|
C18H19FO4S |
详情 |
详情
|
(XI) |
32990 |
(1R)-1-[(4-fluorophenoxy)methyl]-4-oxobutyl benzenesulfonate
|
|
C17H17FO5S |
详情 |
详情
|
(XII) |
14182 |
ethyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate; (Carbethoxymethylene)triphenylphosphorane
|
1099-45-2 |
C22H21O2P |
详情 | 详情
|
(XIII) |
32991 |
ethyl (E,6R)-7-(4-fluorophenoxy)-6-[(phenylsulfonyl)oxy]-2-heptenoate
|
|
C21H23FO6S |
详情 |
详情
|
(XIV) |
32992 |
(1R,4E)-1-[(4-fluorophenoxy)methyl]-6-hydroxy-4-hexenyl benzenesulfonate
|
|
C19H21FO5S |
详情 |
详情
|
(XV) |
32993 |
(1R)-1-[(4-fluorophenoxy)methyl]-3-[(2R,3S)-3-(hydroxymethyl)oxiranyl]propyl benzenesulfonate
|
|
C19H21FO6S |
详情 |
详情
|
(XVI) |
32994 |
(1R)-3-[(2R,3R)-3-(chloromethyl)oxiranyl]-1-[(4-fluorophenoxy)methyl]propyl benzenesulfonate
|
|
C19H20ClFO5S |
详情 |
详情
|
合成路线61
该中间体在本合成路线中的序号:
(II) The enantiomerically pure benzodioxane derivative (VIII) was obtained in a straightforward route including five steps starting from pyrocatechin (I). Racemic (VI) was then resolved by means of crystallization with (-)-O,O'-dibenzoyl-L-tartaric acid.
【1】
Matyus, P.; GYKI-16084. Drugs Fut 1999, 24, 10, 1072.
|
【2】
3(2H)-Pyridazinone derivs. and pharmaceutical compsns. containing these cpds.. WO 9638441 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
18522 |
3-amino-1-propanol
|
156-87-6 |
C3H9NO |
详情 | 详情
|
(I) |
11599 |
o-Dihydroxybenzene; Catechol; Pyrocatechol
|
120-80-9 |
C6H6O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
28714 |
2,3-dihydro-1,4-benzodioxin-2-ylmethanol
|
3663-82-9 |
C9H10O3 |
详情 | 详情
|
(IV) |
20959 |
2,3-dihydro-1,4-benzodioxin-2-ylmethyl 4-methylbenzenesulfonate
|
|
C16H16O5S |
详情 |
详情
|
(V) |
20960 |
3-[(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)amino]-1-propanol
|
|
C12H17NO3 |
详情 |
详情
|
(VI) |
28715 |
3-chloro-N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-1-propanamine
|
|
C12H16ClNO2 |
详情 |
详情
|
(VII) |
16186 |
(2R,3R)-2,3-bis(benzoyloxy)butanedioic acid |
|
C18H14O8 |
详情 |
详情
|
(VIII) |
28716 |
3-chloro-N-[(2R)-2,3-dihydro-1,4-benzodioxin-2-ylmethyl]-1-propanamine
|
|
C12H16ClNO2 |
详情 |
详情
|
合成路线62
该中间体在本合成路线中的序号:
(III) Esterification of p-hydroxyphenylacetic acid (I) with NaHSO4 in refluxing butanol provides butyl acetate derivative (II), which is then subjected to reaction with epichlorohydrin (III) in pyridine to furnish a mixture of epoxypropane (IV) and chloro derivative (V). Treatment of the mixture (IV)/(V) with HCl affords derivative (VI), which is then selectively acylated by means of Lipase Amano PS (LAPS) and vinyl acetate or acetic anhydride/diisopropyl ether to yield compound (S)-(VII).
Treatment of the mixture (IV)/(V) with acetyl chloride gives derivative (VIII), which is selectively deacylated using LAPS in butanol/diisopropyl ether to afford derivative (S)-(IX).
Coupling of derivative (S)-(VII) with isopropylamine (X) in H2O, followed by removal of the acetyl group with NaOH furnishes derivative (XI) (alternatively, (XI) can also be synthesized by coupling of (S)-(IX) with amine (X)). Finally, conversion of (XI) into the desired product is achieved by treatment with ammonium hydroxide in MeOH.
【1】
Banerji, A.A.; Bevinakatti, H.S.; Lipase catalysis in organic solvents. Application to the synthesis of (R)- and (S)-atenolol. J Org Chem 1992, 57, 22, 6003.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V),(VI) |
51078 |
butyl 2-[4-(3-chloro-2-hydroxypropoxy)phenyl]acetate
|
|
C15H21ClO4 |
详情 |
详情
|
(S)-(VII) |
51079 |
butyl 2-(4-[[(2R)-2-(acetoxy)-3-chloropropyl]oxy]phenyl)acetate
|
|
C17H23ClO5 |
详情 |
详情
|
(S)-(IX) |
51080 |
butyl 2-(4-[[(2R)-3-chloro-2-hydroxypropyl]oxy]phenyl)acetate
|
|
C15H21ClO4 |
详情 |
详情
|
(I) |
18430 |
2-(4-Hydroxyphenyl)acetic acid; 4-Hydroxyphenylacetic acid
|
156-38-7 |
C8H8O3 |
详情 | 详情
|
(II) |
51075 |
butyl 2-(4-hydroxyphenyl)acetate
|
|
C12H16O3 |
详情 |
详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
51077 |
butyl 2-[4-(2-oxiranylmethoxy)phenyl]acetate
|
|
C15H20O4 |
详情 |
详情
|
(VIII) |
51082 |
butyl 2-[4-[2-(acetoxy)-3-chloropropoxy]phenyl]acetate
|
|
C17H23ClO5 |
详情 |
详情
|
(X) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
(XI) |
51081 |
butyl 2-(4-[[(2S)-2-hydroxy-3-(isopropylamino)propyl]oxy]phenyl)acetate
|
|
C18H29NO4 |
详情 |
详情
|
合成路线63
该中间体在本合成路线中的序号:
(I) Condensation of epichlorohydrin (I) with N-benzylethanolamine (II) in the presence of sulfuric acid afforded the (chloromethyl)morpholine (III). Halogen displacement in (III) by potassium phthalimide (IV) provided the substituted phthalimide (V). Further hydrazinolysis of (V) furnished racemic (aminomethyl)morpholine (VI) (1). The desired (S) enantiomer (VII) was obtained by crystallization of (VI) as the dibenzoyl-D-tartaric acid salt, followed by liberation of the base with NaOH. Eschweiler-Clarke reductive methylation of (VII) with formaldehyde and formic acid produced the dimethylamino derivative (VIII). The N-benzyl groupof (VIII) was then cleaved by transfer hydrogenation in the presence of hydrazine and Pd/C yielding chiral morpholine (IX). Finally, coupling of this morpholine (IX) with the difluoroqyuinolone boron chelate (X) provided the title morpholino quinolone.
【1】
Sakurai, N.; Sano, M.; Hirayama, F.; Kuroda, T.; Uemori, S.; Moriguchi, A.; Yamamoto, K.; Ikeda, Y.; Kawakita, T.; Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents. Bioorg Med Chem Lett 1998, 8, 16, 2185. |
【2】
Uemori, S.; Hirayama, F.; Moriguchi, A.; Sano, M.; Yokoyama, Y.; Ikeda, Y.; Miyoshi, M.; Sakurai, N.; Yamamoto, K.; Kawakita, T.; Synthesis and anti-Helicobacter pylori activity of Y-34867, a new 7-morpholinoquinolone. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-85. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
25630 |
2-(benzylamino)-1-ethanol
|
104-63-2 |
C9H13NO |
详情 | 详情
|
(III) |
13396 |
4-Benzyl-2-(chloromethyl)morpholine
|
|
C12H16ClNO |
详情 |
详情
|
(IV) |
10926 |
(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium
|
|
C8H4KNO2 |
详情 |
详情
|
(V) |
13398 |
2-[(4-Benzyl-2-morpholinyl)methyl]-1H-isoindole-1,3(2H)-dione
|
|
C20H20N2O3 |
详情 |
详情
|
(VI) |
13399 |
(4-Benzyl-2-morpholinyl)methylamine; (4-Benzyl-2-morpholinyl)methanamine
|
|
C12H18N2O |
详情 |
详情
|
(VII) |
25362 |
1,4,8,11-Tetraazacyclotetradecane
|
295-37-4 |
C10H24N4 |
详情 | 详情
|
(VIII) |
25633 |
N-[[(2S)-4-benzylmorpholinyl]methyl]-N,N-dimethylamine
|
|
C14H22N2O |
详情 |
详情
|
(IX) |
25634 |
N,N-dimethyl-N-[(2R)morpholinylmethyl]amine
|
|
C7H16N2O |
详情 |
详情
|
(X) |
25635 |
1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid diacetoxyboron complex
|
|
C18H16BF2NO8 |
详情 |
详情
|
合成路线64
该中间体在本合成路线中的序号:
(IX) Condensation of isonicotinamide (I) with 1-chloro-2,4-dinitrobenzene (II) gave quaternary pyridinium salt (III). This was further converted into pyridinium salt (V) by treatment with 2-methoxyaniline (IV) in MeOH. Catalytic transfer hydrogenation of the pyridine ring of (V) provided piperidine (VI). The amide function of (VI) was then reduced to amine (VII) using either borane-dimethyl sulfide complex or LiAlH4. Condensation of 4-chlorocatechol (VIII) with epichlorohydrin (IX) in aqueous KOH produced a mixture of regioisomeric benzodioxans (X) and (XI), from which the major 7-chloro isomer (X) was isolated by flash chromatography after treatment with tosyl chloride and pyridine yielding tosylate (XII). This compound was finally coupled with amine (VII) in the presence of K2CO3 and KI in boiling acetonitrile.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25191 |
isonicotinamide
|
1453-82-3 |
C6H6N2O |
详情 | 详情
|
(II) |
10378 |
1-Chloro-2,4-dinitrobenzene
|
97-00-7 |
C6H3ClN2O4 |
详情 | 详情
|
(III) |
25192 |
4-(aminocarbonyl)-1-(2,4-dinitrophenyl)pyridinium chloride
|
475-25-2 |
C12H9ClN4O5 |
详情 | 详情
|
(IV) |
25193 |
2-methoxyphenylamine; 2-methoxyaniline
|
517-28-2 |
C7H9NO |
详情 | 详情
|
(V) |
25194 |
4-(aminocarbonyl)-1-(2-methoxyphenyl)pyridinium chloride
|
|
C13H13ClN2O2 |
详情 |
详情
|
(VI) |
25195 |
1-(2-methoxyphenyl)-4-piperidinecarboxamide
|
|
C13H18N2O2 |
详情 |
详情
|
(VII) |
25196 |
[1-(2-methoxyphenyl)-4-piperidinyl]methylamine; [1-(2-methoxyphenyl)-4-piperidinyl]methanamine
|
|
C13H20N2O |
详情 |
详情
|
(VIII) |
25197 |
4-chloro-1,2-benzenediol
|
2138-22-9 |
C6H5ClO2 |
详情 | 详情
|
(IX) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(X) |
25199 |
(7-chloro-2,3-dihydro-1,4-benzodioxin-2-yl)methanol
|
|
C9H9ClO3 |
详情 |
详情
|
(XI) |
25198 |
(6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl)methanol
|
|
C9H9ClO3 |
详情 |
详情
|
(XII) |
25200 |
(7-chloro-2,3-dihydro-1,4-benzodioxin-2-yl)methyl 4-methylbenzenesulfonate
|
|
C16H15ClO5S |
详情 |
详情
|
合成路线65
该中间体在本合成路线中的序号:
(II) Alkylation of 4-[2,3-dinitroxy)propoxymethyl]phenol (I) with epichlorhydrin (II) in the presence of NaOH provided the corresponding epoxypropoxy derivative (III). Then, epoxide opening with isopropylamine (IV) in refluxing MeOH furnished the desired amino alcohol.
【1】
Prat Quinones, M.; Pi Sallent, J.; Vedrilla Veit, D. (Almirall Prodesfarma, SA); 1-Aryloxy-3-alkylamino-2-propanol nitrate esters, the use thereof and corresponding pharmaceutical compsn.. EP 0637583; JP 1995089910 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36607 |
4-[[2,3-bis(nitrooxy)propoxy]methyl]phenol
|
|
C10H12N2O8 |
详情 |
详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
36608 |
2-[(4-[[2,3-bis(nitrooxy)propoxy]methyl]phenoxy)methyl]oxirane; 4-[[2,3-bis(nitrooxy)propoxy]methyl]phenyl 2-oxiranylmethyl ether
|
|
C13H16N2O9 |
详情 |
详情
|
(IV) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线66
该中间体在本合成路线中的序号:
(II) N-(2,3-Epoxypropyl)piperidine (III), prepared from piperidine (I) and epichlorhydrin (II), was condensed with nicotinic acid amidoxime (IV) in the presence of basic catalysts, such as NaOH, t-BuOK, Al2O3 or SnO2, in hot DMF to provide the title compound, which was finally converted to the dihydrochloride salt.
【1】
Somfai, E,; Bertok, B.; Szekely, I.; Takacs, K.; Thurner, A.; Gajary, A.; Botar, S.; Nagy, L. (Chinoin Pharmaceutical and Chemical Works Co., Ltd.); Improved process for the preparation of amidoxime derivs.. WO 9008131 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10158 |
Piperidine
|
110-89-4 |
C5H11N |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
24452 |
1-(2-oxiranylmethyl)piperidine
|
|
C8H15NO |
详情 |
详情
|
(IV) |
33684 |
N'-hydroxy-3-pyridinecarboximidamide
|
|
C6H7N3O |
详情 |
详情
|
合成路线67
该中间体在本合成路线中的序号:
(III) The acylation of 7-hydroxy-3,4-dihydro-2H-1,4-benzoxazine (I) with acetic anhydride gives the N-acetyl derivative (II), which is condensed with epichlorohydrin (III) by means of K2CO3 at 90-5 C yielding 4-acetyl-7-(2,3-epoxypropoxy)-3,4-dihydro-2H-1,4-benzoxazine (IV). Finally, the addition of 3,4-dimethoxybenzylamine (V) to the epoxy group of (IV) in hot isopropanol affords the target compound.
【1】
Iakovou, K.; et al.; Synthesis of oxypropanolamine derivatives of 3,4-dihydro-2H-1,4-benzoxazine, beta-adrenergic affinity, inotropic, chronotropic and coronary vasodilating activities. Eur J Med Chem 1999, 34, 11, 903.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
38404 |
3,4-dihydro-2H-1,4-benzoxazin-7-ol
|
|
C8H9NO2 |
详情 |
详情
|
(II) |
38405 |
1-(7-hydroxy-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-1-ethanone
|
|
C10H11NO3 |
详情 |
详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
38406 |
1-[7-(2-oxiranylmethoxy)-2,3-dihydro-4H-1,4-benzoxazin-4-yl]-1-ethanone
|
|
C13H15NO4 |
详情 |
详情
|
(V) |
13920 |
(3,4-Dimethoxyphenyl)methanamine; 3,4-Dimethoxybenzylamine; Veratrylamine
|
5763-61-1 |
C9H13NO2 |
详情 | 详情
|
合成路线68
该中间体在本合成路线中的序号:
(II) The condensation of vanillin (I) with epichlorohydrin (II) in ethanolic NaOH produced the glycidyl ether (III). Epoxide ring opening in (III) by means of tert-butylamine (IV) in EtOH furnished amino alcohol (V). The title dihydropyridine derivative was then obtained by reaction between aldehyde (V), methyl acetoacetate (VI), ammonia under Hantzsch condensation conditions, and was isolated after conversion to the hydrochloride salt.
【1】
Liang, J.-C.; Chen, I.-J.; Tsai, C.-H.; Liou, S.-F.; Wang, C.-S.; Yeh, J.-L.; The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg Med Chem 2002, 10, 3, 719. |
【2】
Donovan, S. (Allergan, Inc.); Method for treating a neoplasm. WO 0209743 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
59599 |
3-methoxy-4-(2-oxiranylmethoxy)benzaldehyde
|
|
C11H12O4 |
详情 |
详情
|
(IV) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(V) |
59600 |
4-[3-(tert-butylamino)-2-hydroxypropoxy]-3-methoxybenzaldehyde
|
|
C15H23NO4 |
详情 |
详情
|
(VI) |
11791 |
methyl 3-oxobutanoate; Methyl acetoacetate
|
105-45-3 |
C5H8O3 |
详情 | 详情
|
合成路线69
该中间体在本合成路线中的序号:
(III) The selective methylation of 5,6,7,8-tetrahydro-5,8-ethanonaphthalene-1,4-diol (I) with dimethylsulfate in a two phase system gives 4-methoxy-5,6,7,8-tetrahydro-5,8-ethano-1-naphthol (II), which is condensed with epichlorohydrin (III) by means of piperidine at 100 C yielding 1-methoxy-4-(2,3-epoxypropoxy)-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (IV). The reaction of (IV) with tert-butylamine (V) at 100 C affords 1-methoxy-4-[3-(tert-butylamino)-2-hydroxypropoxy]-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (VI), which is finally demethylated by treatment with pyridine hydrochloride at 160 C
【1】
Blancafort, P.; Serradell, M.N.; Castaner, J.; McGillion, F.B.; Nafetolol. Drugs Fut 1981, 6, 2, 92.
|
【2】
Momiyama, N.; Ichikawa, Y.; Hasegawa, S.; Ishikawa, T.; Matsuyama, R.; Miazaki, K.; Shimada, H.; Targeting MMP-7 via antisense oligonucleotide shows anti-metastatic effects in a colon cancer murine model. Eur J Med Chem 1974, 9, 5, 501.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
61070 |
tricyclo[6.2.2.0~2,7~]dodeca-2,4,6-triene-3,6-diol
|
|
C12H14O2 |
详情 |
详情
|
(II) |
61071 |
6-methoxytricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-ol
|
|
C13H16O2 |
详情 |
详情
|
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
60172 |
4,5,6,7-tetrahydro-1H-cyclopenta[a]pyrrolo[3,4-c]carbazole-1,3(2H)-dione
|
|
C17H12N2O2 |
详情 |
详情
|
(V) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VI) |
60173 |
10-bromo-4,5,6,7-tetrahydro-1H-cyclopenta[a]pyrrolo[3,4-c]carbazole-1,3(2H)-dione
|
|
C17H11BrN2O2 |
详情 |
详情
|
合成路线70
该中间体在本合成路线中的序号:
(III) The selective hydrolysis of 1,4-diacetoxy-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (VII) with diethylamine in methanol gives 4-acetoxy-5,6,7,8-tetrahydro-5,8-ethano-1-naphthol (VIII), which is condensed with epichlorohydrin (III) by means of piperidine at 90 C to afford 1-acetoxy-4-(2,3-epoxypropoxy)-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (VII). The reaction of (IX) with tert-butylamine (V) in refluxing toluene gives 1-acetoxy-4-[3-(tert-butylamino)-2-hydroxypropoxy]-5,6,7,8-tetrahydro-5,8-ethanonaphthalene (X), which is finally hydrolyzed with dry HCl in refluxing methanol
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(VII) |
61074 |
6-(acetyloxy)tricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-yl acetate
|
|
C16H18O4 |
详情 |
详情
|
(VIII) |
61075 |
6-hydroxytricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-yl acetate
|
|
C14H16O3 |
详情 |
详情
|
(IX) |
61076 |
6-(2-oxiranylmethoxy)tricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-yl acetate
|
|
C17H20O4 |
详情 |
详情
|
(X) |
61077 |
6-[3-(tert-butylamino)-2-hydroxypropoxy]tricyclo[6.2.2.0~2,7~]dodeca-2,4,6-trien-3-yl acetate
|
|
C21H31NO4 |
详情 |
详情
|
合成路线71
该中间体在本合成路线中的序号:
(IV) The acetylation of 4-acetamidophenol (I) with acetyl chloride in refluxing benzene gives 4-acetoxyacetanilide (II), which by a Fries reaction with AlCl3 at 170 C is converted into 2-hydroxy-5-acetamidoacetophenone (III). (1,2) The reaction of (III) with epichlorohydrin (IV) by means of sodium ethoxide in refluxing ethanol affords 1-(2-acetyl-4-acetamidophenoxy)-2,3-epoxypropane (V), which is finally treated with isopropylamine (VI) in refluxing ethanol. (1-3)
【1】
Woolbridge, K.R.H.; Basil, B (May & Baker, Ltd.); ZA 6808345 .
|
【2】
Basil, B.; et al.; New series of cardioselective adrenergic beta-receptor blocking compounds. 1-(2-Acyl-4-acylaminophenoxy)3-isopropylaminopropan-2-ols. J Med Chem 1976, 19, 3, 399.
|
【3】
Woolbridge, K.R.H.; Basil, B. (May & Baker, Ltd.); BE 715205; CA 834734; CH 485663; CH 489467; FR 1570087; FR M7616; GB 1231783; GB 681537; JP 7134414; NL 6806946; ZA 6803130 .
|
【4】
Blancafort, P.; Serradell, M.N.; Castaner, J.; Weetman, D.F.; Diacetolol hydrochloride. Drugs Fut 1981, 6, 8, 467.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21611 |
4'-Hydroxyacetanilide;4-Acetamidophenol;N-Acetyl-4-aminophenol;Paracetamol;Acetaminophen;p-Hydroxyacetanilide; Paracetamol; N-(4-hydroxyphenyl)acetamide |
103-90-2 |
C8H9NO2 |
详情 | 详情
|
(II) |
60980 |
4-(acetylamino)phenyl acetate
|
|
C10H11NO3 |
详情 |
详情
|
(III) |
21612 |
N-(3-acetyl-4-hydroxyphenyl)acetamide
|
|
C10H11NO3 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
60981 |
N-[3-acetyl-4-(2-oxiranylmethoxy)phenyl]acetamide
|
|
C13H15NO4 |
详情 |
详情
|
(VI) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
合成路线72
该中间体在本合成路线中的序号:
(II) The condensation of o-(methylthio)phenol (I) with epichlorohydrin (II) by means of sodium hydroxide in water gives 3-[o-(methylthio)phenoxy]-1,2-epoxypropane (III), which is then treated with isopropylamine (IV) in hot water and finally with ethanolic HCl
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
28075 |
2-(methylsulfanyl)phenol
|
1073-29-6 |
C7H8OS |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
60944 |
2-(methylsulfanyl)phenyl 2-oxiranylmethyl ether; 2-{[2-(methylsulfanyl)phenoxy]methyl}oxirane
|
|
C10H12O2S |
详情 |
详情
|
(IV) |
23933 |
2-Propanamine; Isopropylamine
|
75-31-0 |
C3H9N |
详情 | 详情
|
(V) |
60945 |
1-(isopropylamino)-3-[2-(methylsulfanyl)phenoxy]-2-propanol
|
|
C13H21NO2S |
详情 |
详情
|
合成路线73
该中间体在本合成路线中的序号:
(VIII) The condensation of vanillin (VII) with epichlorohydrin (VIII) in ethanolic NaOH produced the glycidyl ether (IX). Epoxide ring opening in (IX) by means of amine (VI) in EtOH furnished amino alcohol (X). The title dihydropyridine derivative was then obtained by reaction between aldehyde (X), methyl acetoacetate (XI), and ammonia under Hantzsch condensation conditions.
【1】
Liang, J.-C.; Chen, I.-J.; Tsai, C.-H.; Liou, S.-F.; Wang, C.-S.; Yeh, J.-L.; The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg Med Chem 2002, 10, 3, 719. |
【2】
Lin, T.-H.; Chen, I.-J.; Guaiacoxypropanolamines with alpha/beta-adrenergic blocking activity. EP 1108710; WO 0005209 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
31105 |
2-(2-methoxyphenoxy)ethylamine; 2-(2-methoxyphenoxy)-1-ethanamine
|
1836-62-0 |
C9H13NO2 |
详情 | 详情
|
(VII) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(VIII) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IX) |
59599 |
3-methoxy-4-(2-oxiranylmethoxy)benzaldehyde
|
|
C11H12O4 |
详情 |
详情
|
(X) |
59618 |
4-(2-hydroxy-3-{[2-(2-methoxyphenoxy)ethyl]amino}propoxy)-3-methoxybenzaldehyde
|
|
C20H25NO6 |
详情 |
详情
|
(XI) |
11791 |
methyl 3-oxobutanoate; Methyl acetoacetate
|
105-45-3 |
C5H8O3 |
详情 | 详情
|
合成路线74
该中间体在本合成路线中的序号:
(IV) Monoalkylation of hydroquinone (I) with decyl bromide (II) under basic conditions provided 4-(decyloxy)phenol (III), which was further condensed with epichlorohydrin (IV) in the presence of Cs2CO3 to yield the glycidyl ether (V). Ring opening of epoxide (V) with allyl 4-hydroxybenzoate (VI) furnished adduct (VII). Then, oxidation of the secondary alcohol (VII) using the Dess-Martin reagent afforded the keto ester (VIII), which upon deprotection with palladium tetrakis(triphenylphosphine) gave the target carboxylic acid.
【1】
Connolly, S.; Botterll, S.; Bennion, C.; et al.; Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A2 based on a 1,3-disubstituted propan-2-one skeleton. J Med Chem 2002, 45, 6, 1348.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13163 |
p-Dihydrobenzene; Hydroquinone
|
123-31-9 |
C6H6O2 |
详情 | 详情
|
(II) |
58570 |
1-Bromodecane; 1-Decyl bromide; Decyl bromide; n-decyl bromide
|
112-29-8 |
C10H21Br |
详情 | 详情
|
(III) |
58571 |
4-Decyloxyphenol
|
|
C16H26O2 |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
58572 |
2-{[4-(decyloxy)phenoxy]methyl}oxirane; decyl 4-(2-oxiranylmethoxy)phenyl ether
|
|
C19H30O3 |
详情 |
详情
|
(VI) |
21022 |
allyl 4-hydroxybenzoate
|
|
C10H10O3 |
详情 |
详情
|
(VII) |
58573 |
allyl 4-{3-[4-(decyloxy)phenoxy]-2-hydroxypropoxy}benzoate
|
|
C29H40O6 |
详情 |
详情
|
(VIII) |
58574 |
allyl 4-{3-[4-(decyloxy)phenoxy]-2-oxopropoxy}benzoate
|
|
C29H38O6 |
详情 |
详情
|
合成路线75
该中间体在本合成路线中的序号:
(II)
【1】
Li SC, Huang HQ, Li ZJ. 2003. Synthesis of a novel antianginal agent Ranolazine. 中国药物化学杂志,13: 283~285 |
【2】
Lu WC, Li YQ, Zhao XG, et aL. 2004. Synthesis of ranolazine中国医药工业杂志,35: 641~642 |
【3】
Wang LS, Feng XY, Zhu HY. 2003. Synthesis of anti-angina drug ranolazine. 广西大学学报,自然科学版,28: 301~303 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
(IV) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(V) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(VI) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|
合成路线76
该中间体在本合成路线中的序号:
(IV)
【1】
Yan J.2007. Synthesis of ranolazine.中国专利申请公开说明书.CN 1915982 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(II) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(III) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(VI) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
合成路线77
该中间体在本合成路线中的序号:
(I)
【1】
Moen AR, Karstad R.Antfiansen T. 2005. Chemo-enzymatic synthesis of both enantiomers of the anti-anginal drug ranolazine. Biocat Biotransfonn, 23: 45~51 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(II) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(III) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
(IV) |
66620 |
1-chloro-3-(2-methoxyphenoxy)propan-2-ol |
|
C10H13ClO3 |
详情 | 详情
|
(V) |
66621 |
1-chloro-3-(2-methoxyphenoxy)propan-2-yl butyrate |
|
C14H19ClO4 |
详情 | 详情
|
(VI) |
66622 |
(R)-1-chloro-3-(2-methoxyphenoxy)propan-2-yl butyrate |
|
C14H19ClO4 |
详情 | 详情
|
(VII) |
66623 |
(R)-1-chloro-3-(2-methoxyphenoxy)propan-2-ol |
|
C10H13ClO3 |
详情 | 详情
|
(VIII) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|
合成路线78
该中间体在本合成路线中的序号:
(I)
【1】
Gutman A, Nisnevich G, Etinger M, et aL. 2005. Process for the preparation of prostaglandin derivatives. U S Pat Appl Publ. Cont-in-part of U S Ser N0478 849. US 2005209337(本专利属于Finetech Laboratories Ltd, Israel) |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
66881 |
1-chloro-3-(3-(trifluoromethyl)phenyl)propan-2-ol |
6310-15-2 |
C10H10ClF3O |
详情 | 详情
|
(IV) |
66882 |
1-chloro-3-(3-(trifluoromethyl)phenyl)propan-2-one |
|
C10H8ClF3O |
详情 | 详情
|
(V) |
66883 |
(Z)-2-(1-chloro-3-(3-(trifluoromethyl)phenyl)propan-2-ylidene)hydrazinecarboxamide |
|
C11H11ClF3N3O |
详情 | 详情
|
(VI) |
66884 |
(Z)-dimethyl (2-(2-carbamoylhydrazono)-3-(3-(trifluoromethyl)phenyl)propyl)phosphonate |
|
C13H17F3N3O4P |
详情 | 详情
|
(VII) |
60587 |
dimethyl 2-oxo-3-[3-(trifluoromethyl)phenyl]propylphosphonate
|
|
C12H14F3O4P |
详情 |
详情
|
(VIII) |
43178 |
(3aR,4S,5R,6aS)-4-(hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
|
31752-99-5 |
C21H20O5 |
详情 | 详情
|
(IX) |
32122 |
(3aR,4R,5R,6aS)-2-oxo-4-[(E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]hexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
|
|
C31H25F3O6 |
详情 |
详情
|
(X) |
66885 |
|
|
C27H34O5Si |
详情 | 详情
|
(XI) |
66886 |
(3aR,4R,5R,6aS)-5-hydroxy tert-butyldimethylsilyl-4-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]hexahydro-2H-cyclopenta[b]furan-2-one |
|
C24H37F3O5Si |
详情 | 详情
|
(XII) |
66887 |
(Z)-7-((1S,3S,5R)-2-((E)-3-((tert-butyldimethylsilyl)oxy)-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid |
|
C29H43F3O5Si |
详情 | 详情
|
(XIII) |
66888 |
(Z)-7-((1S,3S,5R)-3,5-dihydroxy-2-((E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoic acid |
|
C23H29F3O6 |
详情 | 详情
|
33504 (II) |
33504 |
3-(trifluoromethyl)phenol
|
98-17-9 |
C7H5F3O |
详情 | 详情
|
合成路线79
该中间体在本合成路线中的序号:
(XI) Cyclization of 2-(chloromethyl)oxirane (XI) with benzhydrylamine (XII) in MeOH, followed by reaction of the resulting compound with Na2CO3 in CH2Cl2 yields 1-benzhydrylazetidin-3-ol (XIII). Catalytic hydrogenolysis of azetidine derivative (XIII) over Pd/C, followed by re-protection with Boc2O in THF, yields carbamate (XIV), which is oxidized to N-Boc-3-oxoazetidine (XV) by means of TEMPO in the presence of KBr in EtOAc . Wittig reaction of ketone (XV) with diethyl cyanomethylphosphonate (XVI) by means of t-BuOK or NaH in THF gives N-Boc-3-(cyanomethylene)azetidine (XVII) , which is deprotected with HCl in acetonitrile to produce azetidin-3-ylideneacetonitrile hydrochloride (XVIII). Finally, azetidine derivative (XVIII) is condensed with ethanesulfonyl chloride (XIX) using DIEA in acetonitrile .
【1】
Rodgers, J.D., Shepard, S., Li, Y.-L., Zhou, J., Liu, P., Meloni, D., Xia, M.(Incyte Corp.). Azetidine and cyclobutane derivatives as JAK inhibitors. CN 102026999, EP 2288610, JP 2011514909, KR 2010121657, KR 2012108042, US 2009233903, US 2012077798, US 8158616, US 8420629, US 2013225556, WO 2009114512. |
【2】
Friedman, P.A., Fridman, J.S., Luchi, M.E., Williams, W.V. (Incyte Corp.). Janus kinase inhibitors for treatment of dry eye and other eye related dis-eases. EP 2349260, JP 2012504639, US 201011416, US 2012301464, WO 2010039939. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
68070 |
2-[1-(ethylsulfonyl)azetidin-3-ylidene]acetonitrile |
|
C7H10N2O2S |
详情 | 详情
|
(XI) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(XII) |
15149 |
alpha-Aminodiphenylmethane; diphenylmethanamine; benzhydrylamine
|
91-00-9 |
C13H13N |
详情 | 详情
|
(XIII) |
12592 |
1-Benzhydryl-3-azetidinol; 1-Benzhydryl-3-hydroxyazetidine;1-benzhydrylazetidin-3-ol |
18621-17-5 |
C16H17NO |
详情 | 详情
|
(XIV) |
68075 |
tert-butyl 3-hydroxyazetidine-1-carboxylate |
141699-55-0 |
C8H15NO3 |
详情 | 详情
|
(XV) |
68076 |
tert-butyl 3-oxoazetidine-1-carboxylate |
398489-26-4 |
C8H13NO3 |
详情 | 详情
|
(XVI) |
10045 |
Diethyl cyanomethylphosphonate
|
2537-48-6 |
C6H12NO3P |
详情 | 详情
|
(XVII) |
68077 |
N-Boc-3-(cyanomethylene)azetidine |
|
C10H14N2O2 |
详情 | 详情
|
(XVIII) |
68078 |
|
|
C5H6N2.HCl |
详情 | 详情
|
(XIX) |
54065 |
Ethanesulfonyl chloride; Ethylsulfonyl chloride
|
594-44-5 |
C2H5ClO2S |
详情 | 详情
|